id	sid	tid	token	lemma	pos
ajird-562	1	1	american	american	PROPN
ajird-562	1	2	journal	journal	PROPN
ajird-562	1	3	of	of	ADP
ajird-562	1	4	interdisciplinary	interdisciplinary	ADJ
ajird-562	1	5	research	research	NOUN
ajird-562	1	6	and	and	CCONJ
ajird-562	1	7	development	development	NOUN
ajird-562	1	8	issn	issn	PROPN
ajird-562	1	9	online	online	NOUN
ajird-562	1	10	:	:	PUNCT
ajird-562	1	11	2771	2771	NUM
ajird-562	1	12	-	-	SYM
ajird-562	1	13	8948	8948	NUM
ajird-562	1	14	website	website	NOUN
ajird-562	1	15	:	:	PUNCT
ajird-562	1	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-562	1	17	volume	volume	NOUN
ajird-562	1	18	14	14	NUM
ajird-562	1	19	,	,	PUNCT
ajird-562	1	20	march	march	PROPN
ajird-562	1	21	,	,	PUNCT
ajird-562	1	22	2023	2023	NUM
ajird-562	1	23	81	81	NUM
ajird-562	2	1	|	|	ADV
ajird-562	2	2	p	p	ADP
ajird-562	2	3	a	a	DET
ajird-562	2	4	g	g	NOUN
ajird-562	2	5	e	e	NOUN
ajird-562	2	6	incidence	incidence	NOUN
ajird-562	2	7	of	of	ADP
ajird-562	2	8	somatic	somatic	ADJ
ajird-562	2	9	diseases	disease	NOUN
ajird-562	2	10	in	in	ADP
ajird-562	2	11	women	woman	NOUN
ajird-562	2	12	with	with	ADP
ajird-562	2	13	uterine	uterine	ADJ
ajird-562	2	14	and	and	CCONJ
ajird-562	2	15	breast	breast	NOUN
ajird-562	2	16	hyperplastic	hyperplastic	ADJ
ajird-562	2	17	diseases	disease	NOUN
ajird-562	2	18	in	in	ADP
ajird-562	2	19	the	the	DET
ajird-562	2	20	perimenopause	perimenopause	NOUN
ajird-562	2	21	askarova	askarova	PROPN
ajird-562	2	22	zebo	zebo	PROPN
ajird-562	2	23	zafarovna	zafarovna	PROPN
ajird-562	2	24	phd	phd	PROPN
ajird-562	2	25	assistant	assistant	NOUN
ajird-562	2	26	of	of	ADP
ajird-562	2	27	the	the	DET
ajird-562	2	28	department	department	NOUN
ajird-562	2	29	of	of	ADP
ajird-562	2	30	obstetrics	obstetric	NOUN
ajird-562	2	31	and	and	CCONJ
ajird-562	2	32	gynecology	gynecology	NOUN
ajird-562	2	33	no.1	no.1	VERB
ajird-562	2	34	samarkand	samarkand	NOUN
ajird-562	2	35	state	state	PROPN
ajird-562	2	36	medical	medical	PROPN
ajird-562	2	37	university	university	PROPN
ajird-562	2	38	,	,	PUNCT
ajird-562	2	39	samarkand	samarkand	PROPN
ajird-562	2	40	,	,	PUNCT
ajird-562	2	41	uzbekistan	uzbekistan	PROPN
ajird-562	2	42	raximova	raximova	VERB
ajird-562	2	43	amira	amira	PROPN
ajird-562	2	44	oybekovna	oybekovna	PROPN
ajird-562	2	45	the	the	DET
ajird-562	2	46	1st	1st	ADJ
ajird-562	2	47	year	year	NOUN
ajird-562	2	48	resident	resident	NOUN
ajird-562	2	49	of	of	ADP
ajird-562	2	50	the	the	DET
ajird-562	2	51	master	master	NOUN
ajird-562	2	52	’s	’s	NOUN
ajird-562	2	53	of	of	ADP
ajird-562	2	54	the	the	DET
ajird-562	2	55	department	department	NOUN
ajird-562	2	56	of	of	ADP
ajird-562	2	57	obstetrics	obstetric	NOUN
ajird-562	2	58	and	and	CCONJ
ajird-562	2	59	gynecology	gynecology	NOUN
ajird-562	2	60	no.1	no.1	VERB
ajird-562	2	61	samarkand	samarkand	NOUN
ajird-562	2	62	state	state	PROPN
ajird-562	2	63	medical	medical	PROPN
ajird-562	2	64	university	university	PROPN
ajird-562	2	65	,	,	PUNCT
ajird-562	2	66	samarkand	samarkand	PROPN
ajird-562	2	67	,	,	PUNCT
ajird-562	2	68	uzbekistan	uzbekistan	PROPN
ajird-562	2	69	abstract	abstract	ADJ
ajird-562	2	70	analysis	analysis	NOUN
ajird-562	2	71	of	of	ADP
ajird-562	2	72	anamnestic	anamnestic	ADJ
ajird-562	2	73	data	datum	NOUN
ajird-562	2	74	revealed	reveal	VERB
ajird-562	2	75	an	an	DET
ajird-562	2	76	increased	increased	ADJ
ajird-562	2	77	level	level	NOUN
ajird-562	2	78	of	of	ADP
ajird-562	2	79	somatic	somatic	ADJ
ajird-562	2	80	pathology	pathology	NOUN
ajird-562	2	81	in	in	ADP
ajird-562	2	82	patients	patient	NOUN
ajird-562	2	83	with	with	ADP
ajird-562	2	84	uterine	uterine	ADJ
ajird-562	2	85	and	and	CCONJ
ajird-562	2	86	mammary	mammary	ADJ
ajird-562	2	87	hyperplastic	hyperplastic	ADJ
ajird-562	2	88	diseases	disease	NOUN
ajird-562	2	89	,	,	PUNCT
ajird-562	2	90	with	with	ADP
ajird-562	2	91	a	a	DET
ajird-562	2	92	prevalence	prevalence	NOUN
ajird-562	2	93	of	of	ADP
ajird-562	2	94	cardiovascular	cardiovascular	ADJ
ajird-562	2	95	and	and	CCONJ
ajird-562	2	96	endocrine	endocrine	ADJ
ajird-562	2	97	diseases	disease	NOUN
ajird-562	2	98	.	.	PUNCT
ajird-562	3	1	thus	thus	ADV
ajird-562	3	2	,	,	PUNCT
ajird-562	3	3	97	97	NUM
ajird-562	3	4	(	(	PUNCT
ajird-562	3	5	77.6	77.6	NUM
ajird-562	3	6	%	%	NOUN
ajird-562	3	7	)	)	PUNCT
ajird-562	3	8	women	woman	NOUN
ajird-562	3	9	in	in	ADP
ajird-562	3	10	the	the	DET
ajird-562	3	11	main	main	ADJ
ajird-562	3	12	group	group	NOUN
ajird-562	3	13	had	have	VERB
ajird-562	3	14	cardiovascular	cardiovascular	ADJ
ajird-562	3	15	disease	disease	NOUN
ajird-562	3	16	and	and	CCONJ
ajird-562	3	17	only	only	ADV
ajird-562	3	18	one	one	NUM
ajird-562	3	19	in	in	ADP
ajird-562	3	20	five	five	NUM
ajird-562	3	21	9	9	NUM
ajird-562	3	22	(	(	PUNCT
ajird-562	3	23	22.5	22.5	NUM
ajird-562	3	24	%	%	NOUN
ajird-562	3	25	)	)	PUNCT
ajird-562	3	26	from	from	ADP
ajird-562	3	27	the	the	DET
ajird-562	3	28	control	control	NOUN
ajird-562	3	29	group	group	NOUN
ajird-562	3	30	.	.	PUNCT
ajird-562	4	1	varicose	varicose	PROPN
ajird-562	4	2	vein	vein	NOUN
ajird-562	4	3	disease	disease	NOUN
ajird-562	4	4	was	be	AUX
ajird-562	4	5	diagnosed	diagnose	VERB
ajird-562	4	6	in	in	ADP
ajird-562	4	7	87	87	NUM
ajird-562	4	8	(	(	PUNCT
ajird-562	4	9	69.6	69.6	NUM
ajird-562	4	10	%	%	NOUN
ajird-562	4	11	)	)	PUNCT
ajird-562	4	12	against	against	ADP
ajird-562	4	13	7	7	NUM
ajird-562	4	14	(	(	PUNCT
ajird-562	4	15	17.5	17.5	NUM
ajird-562	4	16	%	%	NOUN
ajird-562	4	17	)	)	PUNCT
ajird-562	4	18	in	in	ADP
ajird-562	4	19	the	the	DET
ajird-562	4	20	control	control	NOUN
ajird-562	4	21	group	group	NOUN
ajird-562	4	22	.	.	PUNCT
ajird-562	5	1	hypertension	hypertension	NOUN
ajird-562	5	2	was	be	AUX
ajird-562	5	3	twice	twice	ADV
ajird-562	5	4	as	as	ADV
ajird-562	5	5	common	common	ADJ
ajird-562	5	6	in	in	ADP
ajird-562	5	7	patients	patient	NOUN
ajird-562	5	8	with	with	ADP
ajird-562	5	9	eh	eh	INTJ
ajird-562	5	10	and	and	CCONJ
ajird-562	5	11	bbc	bbc	PROPN
ajird-562	5	12	(	(	PUNCT
ajird-562	5	13	12(9.6	12(9.6	NUM
ajird-562	5	14	%	%	NOUN
ajird-562	5	15	)	)	PUNCT
ajird-562	5	16	vs.	vs.	ADP
ajird-562	5	17	2(5	2(5	NUM
ajird-562	5	18	%	%	NOUN
ajird-562	5	19	)	)	PUNCT
ajird-562	5	20	,	,	PUNCT
ajird-562	5	21	respectively	respectively	ADV
ajird-562	5	22	)	)	PUNCT
ajird-562	5	23	.	.	PUNCT
ajird-562	6	1	keywords	keyword	NOUN
ajird-562	6	2	:	:	PUNCT
ajird-562	6	3	endometrial	endometrial	ADJ
ajird-562	6	4	hyperplasia	hyperplasia	NOUN
ajird-562	6	5	,	,	PUNCT
ajird-562	6	6	mastopathy	mastopathy	ADJ
ajird-562	6	7	,	,	PUNCT
ajird-562	6	8	somatic	somatic	ADJ
ajird-562	6	9	disease	disease	NOUN
ajird-562	6	10	.	.	PUNCT
ajird-562	7	1	timely	timely	ADJ
ajird-562	7	2	detection	detection	NOUN
ajird-562	7	3	and	and	CCONJ
ajird-562	7	4	treatment	treatment	NOUN
ajird-562	7	5	of	of	ADP
ajird-562	7	6	breast	breast	NOUN
ajird-562	7	7	cancer	cancer	NOUN
ajird-562	7	8	contributes	contribute	VERB
ajird-562	7	9	to	to	ADP
ajird-562	7	10	its	its	PRON
ajird-562	7	11	prevention	prevention	NOUN
ajird-562	7	12	.	.	PUNCT
ajird-562	8	1	it	it	PRON
ajird-562	8	2	is	be	AUX
ajird-562	8	3	now	now	ADV
ajird-562	8	4	recognized	recognize	VERB
ajird-562	8	5	by	by	ADP
ajird-562	8	6	specialists	specialist	NOUN
ajird-562	8	7	that	that	SCONJ
ajird-562	8	8	breast	breast	NOUN
ajird-562	8	9	and	and	CCONJ
ajird-562	8	10	genital	genital	ADJ
ajird-562	8	11	diseases	disease	NOUN
ajird-562	8	12	are	be	AUX
ajird-562	8	13	interdependent	interdependent	ADJ
ajird-562	8	14	.	.	PUNCT
ajird-562	9	1	patients	patient	NOUN
ajird-562	9	2	with	with	ADP
ajird-562	9	3	hyperplastic	hyperplastic	ADJ
ajird-562	9	4	processes	process	NOUN
ajird-562	9	5	in	in	ADP
ajird-562	9	6	the	the	DET
ajird-562	9	7	internal	internal	ADJ
ajird-562	9	8	genital	genital	ADJ
ajird-562	9	9	organs	organ	NOUN
ajird-562	9	10	,	,	PUNCT
ajird-562	9	11	including	include	VERB
ajird-562	9	12	the	the	DET
ajird-562	9	13	endometrium	endometrium	NOUN
ajird-562	9	14	,	,	PUNCT
ajird-562	9	15	constitute	constitute	VERB
ajird-562	9	16	the	the	DET
ajird-562	9	17	highest	high	ADJ
ajird-562	9	18	risk	risk	NOUN
ajird-562	9	19	group	group	NOUN
ajird-562	9	20	for	for	ADP
ajird-562	9	21	the	the	DET
ajird-562	9	22	development	development	NOUN
ajird-562	9	23	of	of	ADP
ajird-562	9	24	breast	breast	NOUN
ajird-562	9	25	pathology	pathology	NOUN
ajird-562	9	26	.	.	PUNCT
ajird-562	10	1	endometrial	endometrial	ADJ
ajird-562	10	2	hyperplastic	hyperplastic	ADJ
ajird-562	10	3	processes	process	NOUN
ajird-562	10	4	(	(	PUNCT
ajird-562	10	5	eh	eh	INTJ
ajird-562	10	6	)	)	PUNCT
ajird-562	10	7	can	can	AUX
ajird-562	10	8	occur	occur	VERB
ajird-562	10	9	at	at	ADP
ajird-562	10	10	any	any	DET
ajird-562	10	11	age	age	NOUN
ajird-562	10	12	,	,	PUNCT
ajird-562	10	13	but	but	CCONJ
ajird-562	10	14	the	the	DET
ajird-562	10	15	incidence	incidence	NOUN
ajird-562	10	16	of	of	ADP
ajird-562	10	17	this	this	DET
ajird-562	10	18	disease	disease	NOUN
ajird-562	10	19	increases	increase	VERB
ajird-562	10	20	significantly	significantly	ADV
ajird-562	10	21	during	during	ADP
ajird-562	10	22	perimenopause	perimenopause	NOUN
ajird-562	10	23	.	.	PUNCT
ajird-562	11	1	the	the	DET
ajird-562	11	2	incidence	incidence	NOUN
ajird-562	11	3	of	of	ADP
ajird-562	11	4	bbc	bbc	PROPN
ajird-562	11	5	peaks	peak	NOUN
ajird-562	11	6	at	at	ADP
ajird-562	11	7	41–50	41–50	NUM
ajird-562	11	8	years	year	NOUN
ajird-562	11	9	of	of	ADP
ajird-562	11	10	age	age	NOUN
ajird-562	11	11	,	,	PUNCT
ajird-562	11	12	and	and	CCONJ
ajird-562	11	13	the	the	DET
ajird-562	11	14	average	average	ADJ
ajird-562	11	15	age	age	NOUN
ajird-562	11	16	of	of	ADP
ajird-562	11	17	breast	breast	NOUN
ajird-562	11	18	cancer	cancer	NOUN
ajird-562	11	19	patients	patient	NOUN
ajird-562	11	20	in	in	ADP
ajird-562	11	21	2002	2002	NUM
ajird-562	11	22	was	be	AUX
ajird-562	11	23	55–57	55–57	NUM
ajird-562	11	24	years	year	NOUN
ajird-562	11	25	,	,	PUNCT
ajird-562	11	26	according	accord	VERB
ajird-562	11	27	to	to	ADP
ajird-562	11	28	the	the	DET
ajird-562	11	29	who	who	PRON
ajird-562	11	30	.	.	PUNCT
ajird-562	12	1	thus	thus	ADV
ajird-562	12	2	,	,	PUNCT
ajird-562	12	3	the	the	DET
ajird-562	12	4	importance	importance	NOUN
ajird-562	12	5	of	of	ADP
ajird-562	12	6	appropriate	appropriate	ADJ
ajird-562	12	7	treatment	treatment	NOUN
ajird-562	12	8	and	and	CCONJ
ajird-562	12	9	management	management	NOUN
ajird-562	12	10	of	of	ADP
ajird-562	12	11	patients	patient	NOUN
ajird-562	12	12	with	with	ADP
ajird-562	12	13	perimenopausal	perimenopausal	NOUN
ajird-562	12	14	bbc	bbc	PROPN
ajird-562	12	15	,	,	PUNCT
ajird-562	12	16	both	both	CCONJ
ajird-562	12	17	when	when	SCONJ
ajird-562	12	18	they	they	PRON
ajird-562	12	19	develop	develop	VERB
ajird-562	12	20	independently	independently	ADV
ajird-562	12	21	and	and	CCONJ
ajird-562	12	22	when	when	SCONJ
ajird-562	12	23	combined	combine	VERB
ajird-562	12	24	with	with	ADP
ajird-562	12	25	endometrial	endometrial	ADJ
ajird-562	12	26	hyperplasia	hyperplasia	NOUN
ajird-562	12	27	,	,	PUNCT
ajird-562	12	28	can	can	AUX
ajird-562	12	29	not	not	PART
ajird-562	12	30	be	be	AUX
ajird-562	12	31	overemphasized	overemphasize	VERB
ajird-562	12	32	[	[	PUNCT
ajird-562	12	33	4,6,7	4,6,7	NOUN
ajird-562	12	34	]	]	PUNCT
ajird-562	12	35	.	.	PUNCT
ajird-562	13	1	endometrial	endometrial	ADJ
ajird-562	13	2	hyperplasia	hyperplasia	NOUN
ajird-562	13	3	(	(	PUNCT
ajird-562	13	4	eh	eh	INTJ
ajird-562	13	5	)	)	PUNCT
ajird-562	13	6	can	can	AUX
ajird-562	13	7	occur	occur	VERB
ajird-562	13	8	at	at	ADP
ajird-562	13	9	any	any	DET
ajird-562	13	10	age	age	NOUN
ajird-562	13	11	,	,	PUNCT
ajird-562	13	12	but	but	CCONJ
ajird-562	13	13	its	its	PRON
ajird-562	13	14	incidence	incidence	NOUN
ajird-562	13	15	increases	increase	VERB
ajird-562	13	16	significantly	significantly	ADV
ajird-562	13	17	during	during	ADP
ajird-562	13	18	perimenopause	perimenopause	NOUN
ajird-562	13	19	.	.	PUNCT
ajird-562	14	1	mammary	mammary	ADJ
ajird-562	14	2	gland	gland	NOUN
ajird-562	14	3	morbidity	morbidity	NOUN
ajird-562	14	4	also	also	ADV
ajird-562	14	5	peaks	peak	VERB
ajird-562	14	6	at	at	ADP
ajird-562	14	7	41	41	NUM
ajird-562	14	8	-	-	SYM
ajird-562	14	9	50	50	NUM
ajird-562	14	10	years	year	NOUN
ajird-562	14	11	of	of	ADP
ajird-562	14	12	age	age	NOUN
ajird-562	14	13	[	[	X
ajird-562	14	14	3,4,7	3,4,7	NUM
ajird-562	14	15	]	]	X
ajird-562	14	16	.	.	PUNCT
ajird-562	15	1	a	a	DET
ajird-562	15	2	number	number	NOUN
ajird-562	15	3	of	of	ADP
ajird-562	15	4	scientific	scientific	ADJ
ajird-562	15	5	papers	paper	NOUN
ajird-562	15	6	related	relate	VERB
ajird-562	15	7	to	to	ADP
ajird-562	15	8	the	the	DET
ajird-562	15	9	diagnosis	diagnosis	NOUN
ajird-562	15	10	and	and	CCONJ
ajird-562	15	11	treatment	treatment	NOUN
ajird-562	15	12	of	of	ADP
ajird-562	15	13	endometrial	endometrial	ADJ
ajird-562	15	14	hyperplastic	hyperplastic	ADJ
ajird-562	15	15	processes	process	NOUN
ajird-562	15	16	indicate	indicate	VERB
ajird-562	15	17	that	that	SCONJ
ajird-562	15	18	this	this	DET
ajird-562	15	19	problem	problem	NOUN
ajird-562	15	20	has	have	AUX
ajird-562	15	21	been	be	AUX
ajird-562	15	22	sufficiently	sufficiently	ADV
ajird-562	15	23	studied	study	VERB
ajird-562	15	24	[	[	X
ajird-562	15	25	5,11	5,11	NUM
ajird-562	15	26	]	]	X
ajird-562	15	27	.	.	PUNCT
ajird-562	16	1	there	there	PRON
ajird-562	16	2	are	be	VERB
ajird-562	16	3	studies	study	NOUN
ajird-562	16	4	by	by	ADP
ajird-562	16	5	domestic	domestic	ADJ
ajird-562	16	6	gynecologists	gynecologist	NOUN
ajird-562	16	7	on	on	ADP
ajird-562	16	8	the	the	DET
ajird-562	16	9	development	development	NOUN
ajird-562	16	10	of	of	ADP
ajird-562	16	11	management	management	NOUN
ajird-562	16	12	tactics	tactic	NOUN
ajird-562	16	13	for	for	ADP
ajird-562	16	14	patients	patient	NOUN
ajird-562	16	15	with	with	ADP
ajird-562	16	16	combined	combined	ADJ
ajird-562	16	17	uterine	uterine	ADJ
ajird-562	16	18	and	and	CCONJ
ajird-562	16	19	mammary	mammary	ADJ
ajird-562	16	20	hyperplastic	hyperplastic	ADJ
ajird-562	16	21	processes	process	NOUN
ajird-562	16	22	[	[	X
ajird-562	16	23	1,12	1,12	NUM
ajird-562	16	24	]	]	X
ajird-562	16	25	.	.	PUNCT
ajird-562	17	1	american	american	PROPN
ajird-562	17	2	journal	journal	PROPN
ajird-562	17	3	of	of	ADP
ajird-562	17	4	interdisciplinary	interdisciplinary	ADJ
ajird-562	17	5	research	research	NOUN
ajird-562	17	6	and	and	CCONJ
ajird-562	17	7	development	development	NOUN
ajird-562	17	8	issn	issn	PROPN
ajird-562	17	9	online	online	NOUN
ajird-562	17	10	:	:	PUNCT
ajird-562	17	11	2771	2771	NUM
ajird-562	17	12	-	-	SYM
ajird-562	17	13	8948	8948	NUM
ajird-562	17	14	website	website	NOUN
ajird-562	17	15	:	:	PUNCT
ajird-562	17	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-562	17	17	volume	volume	NOUN
ajird-562	17	18	14	14	NUM
ajird-562	17	19	,	,	PUNCT
ajird-562	17	20	march	march	PROPN
ajird-562	17	21	,	,	PUNCT
ajird-562	17	22	2023	2023	NUM
ajird-562	17	23	82	82	NUM
ajird-562	18	1	|	|	ADV
ajird-562	18	2	p	p	NOUN
ajird-562	18	3	a	a	DET
ajird-562	18	4	g	g	NOUN
ajird-562	18	5	e	e	PROPN
ajird-562	18	6	a	a	DET
ajird-562	18	7	factor	factor	NOUN
ajird-562	18	8	damaging	damage	VERB
ajird-562	18	9	any	any	DET
ajird-562	18	10	part	part	NOUN
ajird-562	18	11	of	of	ADP
ajird-562	18	12	the	the	DET
ajird-562	18	13	menstrual	menstrual	ADJ
ajird-562	18	14	regulation	regulation	NOUN
ajird-562	18	15	system	system	NOUN
ajird-562	18	16	may	may	AUX
ajird-562	18	17	be	be	AUX
ajird-562	18	18	etiological	etiological	ADJ
ajird-562	18	19	for	for	ADP
ajird-562	18	20	the	the	DET
ajird-562	18	21	occurrence	occurrence	NOUN
ajird-562	18	22	of	of	ADP
ajird-562	18	23	this	this	DET
ajird-562	18	24	pathology	pathology	NOUN
ajird-562	18	25	.	.	PUNCT
ajird-562	19	1	these	these	PRON
ajird-562	19	2	include	include	VERB
ajird-562	19	3	overexertion	overexertion	NOUN
ajird-562	19	4	,	,	PUNCT
ajird-562	19	5	psychological	psychological	ADJ
ajird-562	19	6	stress	stress	NOUN
ajird-562	19	7	,	,	PUNCT
ajird-562	19	8	hypovitaminosis	hypovitaminosis	NOUN
ajird-562	19	9	,	,	PUNCT
ajird-562	19	10	intoxication	intoxication	NOUN
ajird-562	19	11	,	,	PUNCT
ajird-562	19	12	genital	genital	ADJ
ajird-562	19	13	and	and	CCONJ
ajird-562	19	14	non	non	ADJ
ajird-562	19	15	-	-	ADJ
ajird-562	19	16	genital	genital	ADJ
ajird-562	19	17	infections	infection	NOUN
ajird-562	19	18	,	,	PUNCT
ajird-562	19	19	somatic	somatic	ADJ
ajird-562	19	20	diseases	disease	NOUN
ajird-562	19	21	,	,	PUNCT
ajird-562	19	22	abortions	abortion	NOUN
ajird-562	19	23	,	,	PUNCT
ajird-562	19	24	pathological	pathological	ADJ
ajird-562	19	25	births	birth	NOUN
ajird-562	19	26	,	,	PUNCT
ajird-562	19	27	and	and	CCONJ
ajird-562	19	28	tumor	tumor	NOUN
ajird-562	19	29	processes	process	NOUN
ajird-562	19	30	of	of	ADP
ajird-562	19	31	various	various	ADJ
ajird-562	19	32	locations	location	NOUN
ajird-562	19	33	[	[	X
ajird-562	19	34	7	7	NUM
ajird-562	19	35	,	,	PUNCT
ajird-562	19	36	8	8	NUM
ajird-562	19	37	]	]	PUNCT
ajird-562	19	38	.	.	PUNCT
ajird-562	20	1	overweight	overweight	NOUN
ajird-562	20	2	and	and	CCONJ
ajird-562	20	3	obesity	obesity	NOUN
ajird-562	20	4	are	be	AUX
ajird-562	20	5	known	know	VERB
ajird-562	20	6	risk	risk	NOUN
ajird-562	20	7	factors	factor	NOUN
ajird-562	20	8	for	for	ADP
ajird-562	20	9	the	the	DET
ajird-562	20	10	development	development	NOUN
ajird-562	20	11	of	of	ADP
ajird-562	20	12	eh	eh	INTJ
ajird-562	20	13	and	and	CCONJ
ajird-562	20	14	bbc	bbc	VERB
ajird-562	20	15	in	in	ADP
ajird-562	20	16	perimenopause	perimenopause	NOUN
ajird-562	20	17	.	.	PUNCT
ajird-562	21	1	their	their	PRON
ajird-562	21	2	effects	effect	NOUN
ajird-562	21	3	appear	appear	VERB
ajird-562	21	4	to	to	PART
ajird-562	21	5	be	be	AUX
ajird-562	21	6	mediated	mediate	VERB
ajird-562	21	7	by	by	ADP
ajird-562	21	8	increased	increase	VERB
ajird-562	21	9	estrogen	estrogen	NOUN
ajird-562	21	10	synthesis	synthesis	NOUN
ajird-562	21	11	in	in	ADP
ajird-562	21	12	adipose	adipose	ADJ
ajird-562	21	13	tissue	tissue	NOUN
ajird-562	21	14	or	or	CCONJ
ajird-562	21	15	by	by	ADP
ajird-562	21	16	an	an	DET
ajird-562	21	17	increase	increase	NOUN
ajird-562	21	18	in	in	ADP
ajird-562	21	19	their	their	PRON
ajird-562	21	20	biological	biological	ADJ
ajird-562	21	21	activity	activity	NOUN
ajird-562	21	22	[	[	X
ajird-562	21	23	4	4	NUM
ajird-562	21	24	]	]	PUNCT
ajird-562	21	25	.	.	PUNCT
ajird-562	22	1	the	the	DET
ajird-562	22	2	«	«	PUNCT
ajird-562	22	3	case	case	NOUN
ajird-562	22	4	-	-	PUNCT
ajird-562	22	5	control	control	NOUN
ajird-562	22	6	»	»	PUNCT
ajird-562	22	7	study	study	NOUN
ajird-562	22	8	results	result	NOUN
ajird-562	22	9	showed	show	VERB
ajird-562	22	10	that	that	SCONJ
ajird-562	22	11	a	a	DET
ajird-562	22	12	bmi	bmi	NOUN
ajird-562	22	13	of	of	ADP
ajird-562	22	14	30	30	NUM
ajird-562	22	15	-	-	SYM
ajird-562	22	16	39	39	NUM
ajird-562	22	17	kg	kg	NOUN
ajird-562	22	18	/	/	SYM
ajird-562	22	19	m	m	NOUN
ajird-562	22	20	increases	increase	VERB
ajird-562	22	21	the	the	DET
ajird-562	22	22	risk	risk	NOUN
ajird-562	22	23	of	of	ADP
ajird-562	22	24	eh	eh	INTJ
ajird-562	22	25	by	by	ADP
ajird-562	22	26	a	a	DET
ajird-562	22	27	factor	factor	NOUN
ajird-562	22	28	of	of	ADP
ajird-562	22	29	3.7	3.7	NUM
ajird-562	22	30	,	,	PUNCT
ajird-562	22	31	an	an	DET
ajird-562	22	32	aeh	aeh	NOUN
ajird-562	22	33	by	by	ADP
ajird-562	22	34	a	a	DET
ajird-562	22	35	factor	factor	NOUN
ajird-562	22	36	of	of	ADP
ajird-562	22	37	4.6	4.6	NUM
ajird-562	22	38	,	,	PUNCT
ajird-562	22	39	with	with	ADP
ajird-562	22	40	bmi	bmi	PROPN
ajird-562	22	41	>	>	X
ajird-562	22	42	40	40	NUM
ajird-562	22	43	kg	kg	NOUN
ajird-562	22	44	/	/	SYM
ajird-562	22	45	m	m	PROPN
ajird-562	22	46	13	13	NUM
ajird-562	22	47	and	and	CCONJ
ajird-562	22	48	23	23	NUM
ajird-562	22	49	times	time	NOUN
ajird-562	22	50	,	,	PUNCT
ajird-562	22	51	respectively	respectively	ADV
ajird-562	22	52	[	[	X
ajird-562	22	53	10	10	NUM
ajird-562	22	54	]	]	PUNCT
ajird-562	22	55	.	.	PUNCT
ajird-562	23	1	the	the	DET
ajird-562	23	2	association	association	NOUN
ajird-562	23	3	between	between	ADP
ajird-562	23	4	diabetes	diabetes	NOUN
ajird-562	23	5	mellitus	mellitus	NOUN
ajird-562	23	6	and	and	CCONJ
ajird-562	23	7	cancer	cancer	NOUN
ajird-562	23	8	is	be	AUX
ajird-562	23	9	well	well	ADV
ajird-562	23	10	known	known	ADJ
ajird-562	23	11	[	[	X
ajird-562	23	12	6	6	NUM
ajird-562	23	13	]	]	PUNCT
ajird-562	23	14	.	.	PUNCT
ajird-562	24	1	according	accord	VERB
ajird-562	24	2	to	to	ADP
ajird-562	24	3	recent	recent	ADJ
ajird-562	24	4	meta	meta	ADJ
ajird-562	24	5	-	-	PUNCT
ajird-562	24	6	analyses	analysis	NOUN
ajird-562	24	7	,	,	PUNCT
ajird-562	24	8	type	type	NOUN
ajird-562	24	9	2	2	NUM
ajird-562	24	10	diabetes	diabetes	NOUN
ajird-562	24	11	mellitus	mellitus	NOUN
ajird-562	24	12	can	can	AUX
ajird-562	24	13	approximately	approximately	ADV
ajird-562	24	14	double	double	VERB
ajird-562	24	15	the	the	DET
ajird-562	24	16	risk	risk	NOUN
ajird-562	24	17	of	of	ADP
ajird-562	24	18	eh	eh	INTJ
ajird-562	24	19	[	[	X
ajird-562	24	20	3,5	3,5	NUM
ajird-562	24	21	]	]	PUNCT
ajird-562	24	22	.	.	PUNCT
ajird-562	25	1	in	in	ADP
ajird-562	25	2	the	the	DET
ajird-562	25	3	perimenopause	perimenopause	NOUN
ajird-562	25	4	period	period	NOUN
ajird-562	25	5	,	,	PUNCT
ajird-562	25	6	there	there	PRON
ajird-562	25	7	are	be	VERB
ajird-562	25	8	peculiarities	peculiarity	NOUN
ajird-562	25	9	of	of	ADP
ajird-562	25	10	hormonal	hormonal	ADJ
ajird-562	25	11	and	and	CCONJ
ajird-562	25	12	non	non	ADJ
ajird-562	25	13	-	-	ADJ
ajird-562	25	14	hormonal	hormonal	ADJ
ajird-562	25	15	treatment	treatment	NOUN
ajird-562	25	16	because	because	SCONJ
ajird-562	25	17	at	at	ADP
ajird-562	25	18	this	this	DET
ajird-562	25	19	age	age	NOUN
ajird-562	25	20	,	,	PUNCT
ajird-562	25	21	the	the	DET
ajird-562	25	22	frequent	frequent	ADJ
ajird-562	25	23	combination	combination	NOUN
ajird-562	25	24	of	of	ADP
ajird-562	25	25	somatic	somatic	ADJ
ajird-562	25	26	diseases	disease	NOUN
ajird-562	25	27	,	,	PUNCT
ajird-562	25	28	endometrial	endometrial	ADJ
ajird-562	25	29	hyperplasia	hyperplasia	NOUN
ajird-562	25	30	,	,	PUNCT
ajird-562	25	31	and	and	CCONJ
ajird-562	25	32	benign	benign	ADJ
ajird-562	25	33	breast	breast	NOUN
ajird-562	25	34	diseases	disease	NOUN
ajird-562	25	35	complicates	complicate	VERB
ajird-562	25	36	the	the	DET
ajird-562	25	37	optimal	optimal	ADJ
ajird-562	25	38	choice	choice	NOUN
ajird-562	25	39	of	of	ADP
ajird-562	25	40	management	management	NOUN
ajird-562	25	41	and	and	CCONJ
ajird-562	25	42	treatment	treatment	NOUN
ajird-562	25	43	tactics	tactic	NOUN
ajird-562	25	44	[	[	X
ajird-562	25	45	8,9	8,9	NUM
ajird-562	25	46	]	]	PUNCT
ajird-562	25	47	.	.	PUNCT
ajird-562	26	1	purpose	purpose	NOUN
ajird-562	26	2	of	of	ADP
ajird-562	26	3	the	the	DET
ajird-562	26	4	study	study	NOUN
ajird-562	26	5	:	:	PUNCT
ajird-562	26	6	to	to	PART
ajird-562	26	7	determine	determine	VERB
ajird-562	26	8	the	the	DET
ajird-562	26	9	incidence	incidence	NOUN
ajird-562	26	10	of	of	ADP
ajird-562	26	11	somatic	somatic	ADJ
ajird-562	26	12	diseases	disease	NOUN
ajird-562	26	13	in	in	ADP
ajird-562	26	14	women	woman	NOUN
ajird-562	26	15	with	with	ADP
ajird-562	26	16	uterine	uterine	ADJ
ajird-562	26	17	hyperplastic	hyperplastic	ADJ
ajird-562	26	18	disease	disease	NOUN
ajird-562	26	19	and	and	CCONJ
ajird-562	26	20	benign	benign	ADJ
ajird-562	26	21	breast	breast	NOUN
ajird-562	26	22	disease	disease	NOUN
ajird-562	26	23	.	.	PUNCT
ajird-562	27	1	materials	material	NOUN
ajird-562	27	2	and	and	CCONJ
ajird-562	27	3	methods	method	NOUN
ajird-562	27	4	of	of	ADP
ajird-562	27	5	the	the	DET
ajird-562	27	6	study	study	NOUN
ajird-562	27	7	.	.	PUNCT
ajird-562	28	1	we	we	PRON
ajird-562	28	2	studied	study	VERB
ajird-562	28	3	125	125	NUM
ajird-562	28	4	perimenopausal	perimenopausal	NOUN
ajird-562	28	5	female	female	ADJ
ajird-562	28	6	patients	patient	NOUN
ajird-562	28	7	with	with	ADP
ajird-562	28	8	indications	indication	NOUN
ajird-562	28	9	of	of	ADP
ajird-562	28	10	eh	eh	INTJ
ajird-562	28	11	and	and	CCONJ
ajird-562	28	12	bbc	bbc	PROPN
ajird-562	28	13	treated	treat	VERB
ajird-562	28	14	at	at	ADP
ajird-562	28	15	the	the	DET
ajird-562	28	16	gynecological	gynecological	ADJ
ajird-562	28	17	department	department	NOUN
ajird-562	28	18	of	of	ADP
ajird-562	28	19	the	the	DET
ajird-562	28	20	multidisciplinary	multidisciplinary	ADJ
ajird-562	28	21	clinic	clinic	NOUN
ajird-562	28	22	under	under	ADP
ajird-562	28	23	samsmu	samsmu	NOUN
ajird-562	28	24	between	between	ADP
ajird-562	28	25	2021	2021	NUM
ajird-562	28	26	and	and	CCONJ
ajird-562	28	27	2023	2023	NUM
ajird-562	28	28	during	during	ADP
ajird-562	28	29	the	the	DET
ajird-562	28	30	follow	follow	NOUN
ajird-562	28	31	-	-	PUNCT
ajird-562	28	32	up	up	NOUN
ajird-562	28	33	period	period	NOUN
ajird-562	28	34	.	.	PUNCT
ajird-562	29	1	control	control	NOUN
ajird-562	29	2	group	group	PROPN
ajird-562	29	3	40	40	NUM
ajird-562	29	4	women	woman	NOUN
ajird-562	29	5	of	of	ADP
ajird-562	29	6	similar	similar	ADJ
ajird-562	29	7	age	age	NOUN
ajird-562	29	8	with	with	ADP
ajird-562	29	9	no	no	DET
ajird-562	29	10	evidence	evidence	NOUN
ajird-562	29	11	of	of	ADP
ajird-562	29	12	any	any	DET
ajird-562	29	13	menstrual	menstrual	ADJ
ajird-562	29	14	irregularities	irregularity	NOUN
ajird-562	29	15	or	or	CCONJ
ajird-562	29	16	breast	breast	NOUN
ajird-562	29	17	disease	disease	NOUN
ajird-562	29	18	.	.	PUNCT
ajird-562	30	1	the	the	DET
ajird-562	30	2	women	woman	NOUN
ajird-562	30	3	's	's	PART
ajird-562	30	4	age	age	NOUN
ajird-562	30	5	ranged	range	VERB
ajird-562	30	6	from	from	ADP
ajird-562	30	7	43	43	NUM
ajird-562	30	8	to	to	PART
ajird-562	30	9	51	51	NUM
ajird-562	30	10	years	year	NOUN
ajird-562	30	11	,	,	PUNCT
ajird-562	30	12	with	with	ADP
ajird-562	30	13	an	an	DET
ajird-562	30	14	average	average	ADJ
ajird-562	30	15	46.9±1.6	46.9±1.6	NUM
ajird-562	30	16	years	year	NOUN
ajird-562	30	17	.	.	PUNCT
ajird-562	31	1	comprehensive	comprehensive	ADJ
ajird-562	31	2	clinical	clinical	ADJ
ajird-562	31	3	and	and	CCONJ
ajird-562	31	4	laboratory	laboratory	NOUN
ajird-562	31	5	examinations	examination	NOUN
ajird-562	31	6	included	include	VERB
ajird-562	31	7	inspection	inspection	NOUN
ajird-562	31	8	of	of	ADP
ajird-562	31	9	the	the	DET
ajird-562	31	10	external	external	ADJ
ajird-562	31	11	genitalia	genitalia	NOUN
ajird-562	31	12	,	,	PUNCT
ajird-562	31	13	vagina	vagina	ADJ
ajird-562	31	14	,	,	PUNCT
ajird-562	31	15	and	and	CCONJ
ajird-562	31	16	cervix	cervix	NOUN
ajird-562	31	17	in	in	ADP
ajird-562	31	18	mirrors	mirror	NOUN
ajird-562	31	19	;	;	PUNCT
ajird-562	31	20	bimanual	bimanual	ADJ
ajird-562	31	21	examination	examination	NOUN
ajird-562	31	22	;	;	PUNCT
ajird-562	31	23	pelvic	pelvic	ADJ
ajird-562	31	24	and	and	CCONJ
ajird-562	31	25	breast	breast	NOUN
ajird-562	31	26	ultrasound	ultrasound	NOUN
ajird-562	31	27	;	;	PUNCT
ajird-562	31	28	endoscopic	endoscopic	ADJ
ajird-562	31	29	examination	examination	NOUN
ajird-562	31	30	of	of	ADP
ajird-562	31	31	the	the	DET
ajird-562	31	32	uterine	uterine	ADJ
ajird-562	31	33	cavity	cavity	NOUN
ajird-562	31	34	;	;	PUNCT
ajird-562	31	35	and	and	CCONJ
ajird-562	31	36	histological	histological	ADJ
ajird-562	31	37	examination	examination	NOUN
ajird-562	31	38	of	of	ADP
ajird-562	31	39	biopsy	biopsy	NOUN
ajird-562	31	40	specimens	specimen	NOUN
ajird-562	31	41	.	.	PUNCT
ajird-562	32	1	digital	digital	ADJ
ajird-562	32	2	mammography	mammography	NOUN
ajird-562	32	3	.	.	PUNCT
ajird-562	33	1	inclusion	inclusion	NOUN
ajird-562	33	2	criteria	criterion	NOUN
ajird-562	33	3	:	:	PUNCT
ajird-562	33	4	perimenopausal	perimenopausal	NOUN
ajird-562	33	5	age	age	NOUN
ajird-562	33	6	,	,	PUNCT
ajird-562	33	7	morphologically	morphologically	ADV
ajird-562	33	8	confirmed	confirm	VERB
ajird-562	33	9	diagnosis	diagnosis	NOUN
ajird-562	33	10	of	of	ADP
ajird-562	33	11	endometrial	endometrial	ADJ
ajird-562	33	12	hyperplasia	hyperplasia	NOUN
ajird-562	33	13	,	,	PUNCT
ajird-562	33	14	absence	absence	NOUN
ajird-562	33	15	of	of	ADP
ajird-562	33	16	antibiotic	antibiotic	ADJ
ajird-562	33	17	therapy	therapy	NOUN
ajird-562	33	18	for	for	ADP
ajird-562	33	19	the	the	DET
ajird-562	33	20	last	last	ADJ
ajird-562	33	21	3	3	NUM
ajird-562	33	22	months	month	NOUN
ajird-562	33	23	for	for	ADP
ajird-562	33	24	objective	objective	ADJ
ajird-562	33	25	assessment	assessment	NOUN
ajird-562	33	26	of	of	ADP
ajird-562	33	27	infection	infection	NOUN
ajird-562	33	28	status	status	NOUN
ajird-562	33	29	,	,	PUNCT
ajird-562	33	30	absence	absence	NOUN
ajird-562	33	31	of	of	ADP
ajird-562	33	32	hormonal	hormonal	ADJ
ajird-562	33	33	therapy	therapy	NOUN
ajird-562	33	34	for	for	ADP
ajird-562	33	35	the	the	DET
ajird-562	33	36	last	last	ADJ
ajird-562	33	37	3	3	NUM
ajird-562	33	38	-	-	SYM
ajird-562	33	39	6	6	NUM
ajird-562	33	40	months	month	NOUN
ajird-562	33	41	.	.	PUNCT
ajird-562	34	1	informed	informed	ADJ
ajird-562	34	2	consent	consent	NOUN
ajird-562	34	3	was	be	AUX
ajird-562	34	4	a	a	DET
ajird-562	34	5	prerequisite	prerequisite	NOUN
ajird-562	34	6	for	for	ADP
ajird-562	34	7	participation	participation	NOUN
ajird-562	34	8	in	in	ADP
ajird-562	34	9	the	the	DET
ajird-562	34	10	study	study	NOUN
ajird-562	34	11	.	.	PUNCT
ajird-562	35	1	exclusion	exclusion	NOUN
ajird-562	35	2	criteria	criterion	NOUN
ajird-562	35	3	:	:	PUNCT
ajird-562	36	1	patients	patient	NOUN
ajird-562	36	2	with	with	ADP
ajird-562	36	3	coagulopathies	coagulopathie	NOUN
ajird-562	36	4	,	,	PUNCT
ajird-562	36	5	iatrogenic	iatrogenic	ADJ
ajird-562	36	6	bleeding	bleeding	NOUN
ajird-562	36	7	,	,	PUNCT
ajird-562	36	8	and	and	CCONJ
ajird-562	36	9	malignant	malignant	ADJ
ajird-562	36	10	diseases	disease	NOUN
ajird-562	36	11	of	of	ADP
ajird-562	36	12	any	any	DET
ajird-562	36	13	localization	localization	NOUN
ajird-562	36	14	were	be	AUX
ajird-562	36	15	excluded	exclude	VERB
ajird-562	36	16	from	from	ADP
ajird-562	36	17	the	the	DET
ajird-562	36	18	study	study	NOUN
ajird-562	36	19	.	.	PUNCT
ajird-562	37	1	american	american	PROPN
ajird-562	37	2	journal	journal	PROPN
ajird-562	37	3	of	of	ADP
ajird-562	37	4	interdisciplinary	interdisciplinary	ADJ
ajird-562	37	5	research	research	NOUN
ajird-562	37	6	and	and	CCONJ
ajird-562	37	7	development	development	NOUN
ajird-562	37	8	issn	issn	PROPN
ajird-562	37	9	online	online	NOUN
ajird-562	37	10	:	:	PUNCT
ajird-562	37	11	2771	2771	NUM
ajird-562	37	12	-	-	SYM
ajird-562	37	13	8948	8948	NUM
ajird-562	37	14	website	website	NOUN
ajird-562	37	15	:	:	PUNCT
ajird-562	37	16	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-562	37	17	volume	volume	NOUN
ajird-562	37	18	14	14	NUM
ajird-562	37	19	,	,	PUNCT
ajird-562	37	20	march	march	PROPN
ajird-562	37	21	,	,	PUNCT
ajird-562	37	22	2023	2023	NUM
ajird-562	37	23	83	83	NUM
ajird-562	38	1	|	|	ADV
ajird-562	38	2	p	p	NOUN
ajird-562	38	3	a	a	DET
ajird-562	38	4	g	g	NOUN
ajird-562	38	5	e	e	NOUN
ajird-562	38	6	results	result	NOUN
ajird-562	38	7	of	of	ADP
ajird-562	38	8	the	the	DET
ajird-562	38	9	study	study	NOUN
ajird-562	38	10	the	the	DET
ajird-562	38	11	study	study	NOUN
ajird-562	38	12	of	of	ADP
ajird-562	38	13	somatic	somatic	ADJ
ajird-562	38	14	pathology	pathology	NOUN
ajird-562	38	15	(	(	PUNCT
ajird-562	38	16	table	table	NOUN
ajird-562	38	17	1	1	NUM
ajird-562	38	18	)	)	PUNCT
ajird-562	38	19	in	in	ADP
ajird-562	38	20	the	the	DET
ajird-562	38	21	patients	patient	NOUN
ajird-562	38	22	revealed	reveal	VERB
ajird-562	38	23	that	that	SCONJ
ajird-562	38	24	half	half	NOUN
ajird-562	38	25	of	of	ADP
ajird-562	38	26	the	the	DET
ajird-562	38	27	patients	patient	NOUN
ajird-562	38	28	in	in	ADP
ajird-562	38	29	the	the	DET
ajird-562	38	30	study	study	NOUN
ajird-562	38	31	group	group	NOUN
ajird-562	38	32	49	49	NUM
ajird-562	38	33	(	(	PUNCT
ajird-562	38	34	39,2±4,4	39,2±4,4	NUM
ajird-562	38	35	%	%	NOUN
ajird-562	38	36	)	)	PUNCT
ajird-562	38	37	had	have	VERB
ajird-562	38	38	chronic	chronic	ADJ
ajird-562	38	39	inflammatory	inflammatory	ADJ
ajird-562	38	40	diseases	disease	NOUN
ajird-562	38	41	of	of	ADP
ajird-562	38	42	the	the	DET
ajird-562	38	43	upper	upper	ADJ
ajird-562	38	44	and	and	CCONJ
ajird-562	38	45	lower	low	ADJ
ajird-562	38	46	respiratory	respiratory	ADJ
ajird-562	38	47	tracts	tract	NOUN
ajird-562	38	48	,	,	PUNCT
ajird-562	38	49	which	which	PRON
ajird-562	38	50	was	be	AUX
ajird-562	38	51	significantly	significantly	ADV
ajird-562	38	52	more	more	ADV
ajird-562	38	53	frequent	frequent	ADJ
ajird-562	38	54	than	than	ADP
ajird-562	38	55	in	in	ADP
ajird-562	38	56	the	the	DET
ajird-562	38	57	control	control	NOUN
ajird-562	38	58	group	group	NOUN
ajird-562	38	59	7	7	NUM
ajird-562	38	60	(	(	PUNCT
ajird-562	38	61	17,5±6	17,5±6	NUM
ajird-562	38	62	%	%	NOUN
ajird-562	38	63	]	]	X
ajird-562	38	64	,	,	PUNCT
ajird-562	38	65	p<0,001	p<0,001	NOUN
ajird-562	38	66	.	.	PUNCT
ajird-562	39	1	every	every	DET
ajird-562	39	2	fifth	fifth	ADJ
ajird-562	39	3	patient	patient	NOUN
ajird-562	39	4	in	in	ADP
ajird-562	39	5	the	the	DET
ajird-562	39	6	main	main	ADJ
ajird-562	39	7	group	group	NOUN
ajird-562	39	8	29(23,2±3,8	29(23,2±3,8	NUM
ajird-562	39	9	%	%	NOUN
ajird-562	39	10	)	)	PUNCT
ajird-562	39	11	and	and	CCONJ
ajird-562	39	12	every	every	DET
ajird-562	39	13	8th	8th	ADJ
ajird-562	39	14	patient	patient	NOUN
ajird-562	39	15	in	in	ADP
ajird-562	39	16	the	the	DET
ajird-562	39	17	control	control	NOUN
ajird-562	39	18	suffered	suffer	VERB
ajird-562	39	19	from	from	ADP
ajird-562	39	20	chronic	chronic	ADJ
ajird-562	39	21	bronchitis	bronchitis	ADP
ajird-562	39	22	5(12,5±5,2%),p<0,05	5(12,5±5,2%),p<0,05	PROPN
ajird-562	39	23	.	.	PUNCT
ajird-562	40	1	chronic	chronic	ADJ
ajird-562	40	2	tonsillitis	tonsillitis	NOUN
ajird-562	40	3	was	be	AUX
ajird-562	40	4	three	three	NUM
ajird-562	40	5	times	time	NOUN
ajird-562	40	6	more	more	ADV
ajird-562	40	7	frequently	frequently	ADV
ajird-562	40	8	reported	report	VERB
ajird-562	40	9	by	by	ADP
ajird-562	40	10	patients	patient	NOUN
ajird-562	40	11	with	with	ADP
ajird-562	40	12	eh	eh	INTJ
ajird-562	40	13	and	and	CCONJ
ajird-562	40	14	bbc	bbc	PROPN
ajird-562	40	15	compared	compare	VERB
ajird-562	40	16	to	to	ADP
ajird-562	40	17	controls	control	NOUN
ajird-562	40	18	,	,	PUNCT
ajird-562	40	19	p<0.001	p<0.001	ADJ
ajird-562	40	20	.	.	PUNCT
ajird-562	41	1	cardiovascular	cardiovascular	ADJ
ajird-562	41	2	diseases	disease	NOUN
ajird-562	41	3	,	,	PUNCT
ajird-562	41	4	predominantly	predominantly	ADV
ajird-562	41	5	varicose	varicose	VERB
ajird-562	41	6	veins	vein	NOUN
ajird-562	41	7	and	and	CCONJ
ajird-562	41	8	hypertension	hypertension	NOUN
ajird-562	41	9	,	,	PUNCT
ajird-562	41	10	affected	affect	VERB
ajird-562	41	11	a	a	DET
ajird-562	41	12	significant	significant	ADJ
ajird-562	41	13	proportion	proportion	NOUN
ajird-562	41	14	of	of	ADP
ajird-562	41	15	women	woman	NOUN
ajird-562	41	16	with	with	ADP
ajird-562	41	17	eh	eh	INTJ
ajird-562	41	18	and	and	CCONJ
ajird-562	41	19	dysfunctional	dysfunctional	ADJ
ajird-562	41	20	veins	vein	NOUN
ajird-562	41	21	,	,	PUNCT
ajird-562	41	22	97	97	NUM
ajird-562	41	23	(	(	PUNCT
ajird-562	41	24	77.6±3.7	77.6±3.7	NUM
ajird-562	41	25	%	%	NOUN
ajird-562	41	26	)	)	PUNCT
ajird-562	41	27	in	in	ADP
ajird-562	41	28	the	the	DET
ajird-562	41	29	study	study	NOUN
ajird-562	41	30	group	group	NOUN
ajird-562	41	31	,	,	PUNCT
ajird-562	41	32	and	and	CCONJ
ajird-562	41	33	only	only	ADV
ajird-562	41	34	one	one	NUM
ajird-562	41	35	in	in	ADP
ajird-562	41	36	five	five	NUM
ajird-562	41	37	,	,	PUNCT
ajird-562	41	38	9(22.5±6.6	9(22.5±6.6	NUM
ajird-562	41	39	%	%	NOUN
ajird-562	41	40	)	)	PUNCT
ajird-562	41	41	in	in	ADP
ajird-562	41	42	the	the	DET
ajird-562	41	43	control	control	NOUN
ajird-562	41	44	group	group	NOUN
ajird-562	41	45	,	,	PUNCT
ajird-562	41	46	p<0.001	p<0.001	PROPN
ajird-562	41	47	.	.	PUNCT
ajird-562	42	1	varicose	varicose	PROPN
ajird-562	42	2	veins	vein	NOUN
ajird-562	42	3	were	be	AUX
ajird-562	42	4	diagnosed	diagnose	VERB
ajird-562	42	5	in	in	ADP
ajird-562	42	6	87(69,6±4,1	87(69,6±4,1	NOUN
ajird-562	42	7	%	%	NOUN
ajird-562	42	8	)	)	PUNCT
ajird-562	42	9	against	against	ADP
ajird-562	42	10	7(17,5±6	7(17,5±6	NUM
ajird-562	42	11	%	%	NOUN
ajird-562	42	12	)	)	PUNCT
ajird-562	42	13	in	in	ADP
ajird-562	42	14	the	the	DET
ajird-562	42	15	control	control	NOUN
ajird-562	42	16	group	group	NOUN
ajird-562	42	17	,	,	PUNCT
ajird-562	42	18	p<0,001	p<0,001	NOUN
ajird-562	42	19	.	.	PUNCT
ajird-562	43	1	hypertensive	hypertensive	ADJ
ajird-562	43	2	disease	disease	NOUN
ajird-562	43	3	was	be	AUX
ajird-562	43	4	twice	twice	ADV
ajird-562	43	5	as	as	ADV
ajird-562	43	6	common	common	ADJ
ajird-562	43	7	in	in	ADP
ajird-562	43	8	patients	patient	NOUN
ajird-562	43	9	with	with	ADP
ajird-562	43	10	eh	eh	INTJ
ajird-562	43	11	and	and	CCONJ
ajird-562	43	12	bbc	bbc	PROPN
ajird-562	43	13	,	,	PUNCT
ajird-562	43	14	12(9.6±2.6	12(9.6±2.6	NUM
ajird-562	43	15	%	%	NOUN
ajird-562	43	16	)	)	PUNCT
ajird-562	43	17	vs	vs	ADP
ajird-562	43	18	2(5±3.4	2(5±3.4	NUM
ajird-562	43	19	%	%	NOUN
ajird-562	43	20	)	)	PUNCT
ajird-562	43	21	,	,	PUNCT
ajird-562	43	22	p<0.05	p<0.05	NOUN
ajird-562	43	23	.	.	PUNCT
ajird-562	44	1	the	the	DET
ajird-562	44	2	main	main	ADJ
ajird-562	44	3	group	group	NOUN
ajird-562	44	4	had	have	VERB
ajird-562	44	5	significantly	significantly	ADV
ajird-562	44	6	more	more	ADV
ajird-562	44	7	frequent	frequent	ADJ
ajird-562	44	8	various	various	ADJ
ajird-562	44	9	urinary	urinary	ADJ
ajird-562	44	10	system	system	NOUN
ajird-562	44	11	diseases	disease	NOUN
ajird-562	44	12	112(89.6±2.7	112(89.6±2.7	PRON
ajird-562	44	13	%	%	NOUN
ajird-562	44	14	)	)	PUNCT
ajird-562	45	1	vs.	vs.	ADP
ajird-562	45	2	14(40±8.3	14(40±8.3	NUM
ajird-562	45	3	%	%	NOUN
ajird-562	45	4	)	)	PUNCT
ajird-562	45	5	,	,	PUNCT
ajird-562	45	6	p<0.001	p<0.001	PROPN
ajird-562	45	7	)	)	PUNCT
ajird-562	45	8	.	.	PUNCT
ajird-562	46	1	chronic	chronic	PROPN
ajird-562	46	2	pyelonephritis	pyelonephritis	PROPN
ajird-562	46	3	was	be	AUX
ajird-562	46	4	the	the	DET
ajird-562	46	5	most	most	ADV
ajird-562	46	6	common	common	ADJ
ajird-562	46	7	in	in	ADP
ajird-562	46	8	the	the	DET
ajird-562	46	9	patients	patient	NOUN
ajird-562	46	10	with	with	ADP
ajird-562	46	11	grave	grave	NOUN
ajird-562	46	12	's	's	PART
ajird-562	46	13	disease	disease	NOUN
ajird-562	46	14	and	and	CCONJ
ajird-562	46	15	bbc	bbc	VERB
ajird-562	46	16	56(44.8±4.4	56(44.8±4.4	NUM
ajird-562	46	17	%	%	NOUN
ajird-562	46	18	)	)	PUNCT
ajird-562	46	19	vs	vs	ADP
ajird-562	46	20	7(17.5±6	7(17.5±6	NUM
ajird-562	46	21	%	%	NOUN
ajird-562	46	22	)	)	PUNCT
ajird-562	46	23	controls	control	NOUN
ajird-562	46	24	,	,	PUNCT
ajird-562	46	25	p<0.05	p<0.05	NOUN
ajird-562	46	26	.	.	PUNCT
ajird-562	47	1	all	all	DET
ajird-562	47	2	18	18	NUM
ajird-562	47	3	patients	patient	NOUN
ajird-562	47	4	in	in	ADP
ajird-562	47	5	both	both	DET
ajird-562	47	6	groups	group	NOUN
ajird-562	47	7	had	have	AUX
ajird-562	47	8	chronic	chronic	ADJ
ajird-562	47	9	cystitis	cystitis	NOUN
ajird-562	47	10	7(5.6±2.1	7(5.6±2.1	NUM
ajird-562	47	11	%	%	NOUN
ajird-562	47	12	)	)	PUNCT
ajird-562	47	13	and	and	CCONJ
ajird-562	47	14	2(5±3.4	2(5±3.4	NUM
ajird-562	47	15	%	%	NOUN
ajird-562	47	16	)	)	PUNCT
ajird-562	47	17	,	,	PUNCT
ajird-562	48	1	respectively	respectively	ADV
ajird-562	48	2	.	.	PUNCT
ajird-562	48	3	table	table	NOUN
ajird-562	48	4	1	1	NUM
ajird-562	48	5	structure	structure	NOUN
ajird-562	48	6	of	of	ADP
ajird-562	48	7	somatic	somatic	ADJ
ajird-562	48	8	pathology	pathology	NOUN
ajird-562	48	9	in	in	ADP
ajird-562	48	10	the	the	DET
ajird-562	48	11	women	woman	NOUN
ajird-562	48	12	surveyed	survey	VERB
ajird-562	48	13	,	,	PUNCT
ajird-562	48	14	m±m	m±m	PROPN
ajird-562	48	15	structure	structure	NOUN
ajird-562	48	16	of	of	ADP
ajird-562	48	17	somatic	somatic	ADJ
ajird-562	48	18	pathology	pathology	NOUN
ajird-562	48	19	main	main	ADJ
ajird-562	48	20	group	group	NOUN
ajird-562	48	21	,	,	PUNCT
ajird-562	48	22	n=125	n=125	NOUN
ajird-562	48	23	control	control	NOUN
ajird-562	48	24	,	,	PUNCT
ajird-562	48	25	n=40	n=40	ADJ
ajird-562	48	26	respiratory	respiratory	ADJ
ajird-562	48	27	diseases	disease	NOUN
ajird-562	48	28	49(39,2±4,4	49(39,2±4,4	NUM
ajird-562	48	29	%	%	NOUN
ajird-562	48	30	)	)	PUNCT
ajird-562	48	31	7(17,5±6%)^^	7(17,5±6%)^^	NUM
ajird-562	48	32	-chronic	-chronic	NOUN
ajird-562	48	33	bronchitis	bronchitis	ADP
ajird-562	48	34	29(23,2±3,8	29(23,2±3,8	NUM
ajird-562	48	35	%	%	NOUN
ajird-562	48	36	)	)	PUNCT
ajird-562	48	37	5(12,5±5,2	5(12,5±5,2	NUM
ajird-562	48	38	%	%	NOUN
ajird-562	48	39	)	)	PUNCT
ajird-562	48	40	*	*	PUNCT
ajird-562	48	41	-chronic	-chronic	VERB
ajird-562	48	42	tonsillitis	tonsillitis	NOUN
ajird-562	48	43	20(16±3,3	20(16±3,3	NUM
ajird-562	48	44	%	%	NOUN
ajird-562	48	45	)	)	PUNCT
ajird-562	48	46	2(5,0±3,4	2(5,0±3,4	NUM
ajird-562	48	47	%	%	NOUN
ajird-562	48	48	)	)	PUNCT
ajird-562	48	49	*	*	PUNCT
ajird-562	49	1	*	*	NOUN
ajird-562	49	2	diseases	disease	NOUN
ajird-562	49	3	of	of	ADP
ajird-562	49	4	the	the	DET
ajird-562	49	5	cardiovascular	cardiovascular	ADJ
ajird-562	49	6	system	system	NOUN
ajird-562	49	7	97(77,6±3,7	97(77,6±3,7	NUM
ajird-562	49	8	%	%	NOUN
ajird-562	49	9	)	)	PUNCT
ajird-562	49	10	9(22,5±6,6	9(22,5±6,6	NUM
ajird-562	49	11	%	%	NOUN
ajird-562	49	12	)	)	PUNCT
ajird-562	49	13	*	*	PUNCT
ajird-562	50	1	*	*	PUNCT
ajird-562	50	2	-varicose	-varicose	ADJ
ajird-562	50	3	vein	vein	ADJ
ajird-562	50	4	disease	disease	NOUN
ajird-562	50	5	87(69,6±4,1	87(69,6±4,1	NOUN
ajird-562	50	6	%	%	NOUN
ajird-562	50	7	)	)	PUNCT
ajird-562	50	8	7(17,5±6	7(17,5±6	NUM
ajird-562	50	9	%	%	NOUN
ajird-562	50	10	)	)	PUNCT
ajird-562	51	1	*	*	PUNCT
ajird-562	51	2	*	*	PUNCT
ajird-562	51	3	hypertension	hypertension	NOUN
ajird-562	51	4	12(9,6±2,6	12(9,6±2,6	NUM
ajird-562	51	5	%	%	NOUN
ajird-562	51	6	)	)	PUNCT
ajird-562	51	7	2(5±3,4	2(5±3,4	NUM
ajird-562	51	8	%	%	NOUN
ajird-562	51	9	)	)	PUNCT
ajird-562	52	1	*	*	PUNCT
ajird-562	52	2	diseases	disease	NOUN
ajird-562	52	3	of	of	ADP
ajird-562	52	4	the	the	DET
ajird-562	52	5	urinary	urinary	ADJ
ajird-562	52	6	system	system	NOUN
ajird-562	52	7	112(89,6±2,7	112(89,6±2,7	NUM
ajird-562	52	8	%	%	NOUN
ajird-562	52	9	)	)	PUNCT
ajird-562	52	10	14(40±8,3	14(40±8,3	NUM
ajird-562	52	11	%	%	NOUN
ajird-562	52	12	)	)	PUNCT
ajird-562	53	1	*	*	PUNCT
ajird-562	53	2	*	*	PUNCT
ajird-562	53	3	-chronic	-chronic	ADJ
ajird-562	53	4	pyelonephritis	pyelonephritis	NOUN
ajird-562	53	5	56(44,8±4,4	56(44,8±4,4	NUM
ajird-562	53	6	%	%	NOUN
ajird-562	53	7	)	)	PUNCT
ajird-562	53	8	7(17,5±6	7(17,5±6	NUM
ajird-562	53	9	%	%	NOUN
ajird-562	53	10	)	)	PUNCT
ajird-562	54	1	*	*	PUNCT
ajird-562	55	1	urolithiasis	urolithiasis	ADJ
ajird-562	55	2	50(40±4,4	50(40±4,4	NUM
ajird-562	55	3	%	%	NOUN
ajird-562	55	4	)	)	PUNCT
ajird-562	55	5	5(12,5±5,2	5(12,5±5,2	NUM
ajird-562	55	6	%	%	NOUN
ajird-562	55	7	)	)	PUNCT
ajird-562	56	1	*	*	PUNCT
ajird-562	56	2	chronic	chronic	ADJ
ajird-562	56	3	cystitis	cystitis	NOUN
ajird-562	56	4	7(5,6±2,1	7(5,6±2,1	NUM
ajird-562	56	5	%	%	NOUN
ajird-562	56	6	)	)	PUNCT
ajird-562	56	7	2(5±3,4	2(5±3,4	NUM
ajird-562	56	8	%	%	NOUN
ajird-562	56	9	)	)	PUNCT
ajird-562	56	10	american	american	PROPN
ajird-562	56	11	journal	journal	PROPN
ajird-562	56	12	of	of	ADP
ajird-562	56	13	interdisciplinary	interdisciplinary	ADJ
ajird-562	56	14	research	research	NOUN
ajird-562	56	15	and	and	CCONJ
ajird-562	56	16	development	development	NOUN
ajird-562	56	17	issn	issn	PROPN
ajird-562	56	18	online	online	NOUN
ajird-562	56	19	:	:	PUNCT
ajird-562	56	20	2771	2771	NUM
ajird-562	56	21	-	-	SYM
ajird-562	56	22	8948	8948	NUM
ajird-562	56	23	website	website	NOUN
ajird-562	56	24	:	:	PUNCT
ajird-562	56	25	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-562	56	26	volume	volume	NOUN
ajird-562	56	27	14	14	NUM
ajird-562	56	28	,	,	PUNCT
ajird-562	56	29	march	march	PROPN
ajird-562	56	30	,	,	PUNCT
ajird-562	56	31	2023	2023	NUM
ajird-562	56	32	84	84	NUM
ajird-562	56	33	|	|	ADV
ajird-562	56	34	p	p	ADP
ajird-562	56	35	a	a	DET
ajird-562	56	36	g	g	NOUN
ajird-562	56	37	e	e	NOUN
ajird-562	56	38	diseases	disease	NOUN
ajird-562	56	39	of	of	ADP
ajird-562	56	40	the	the	DET
ajird-562	56	41	endocrine	endocrine	ADJ
ajird-562	56	42	system	system	NOUN
ajird-562	56	43	106(84,8±3,2	106(84,8±3,2	NUM
ajird-562	56	44	%	%	NOUN
ajird-562	56	45	)	)	PUNCT
ajird-562	56	46	7(17,5±6	7(17,5±6	NUM
ajird-562	56	47	%	%	NOUN
ajird-562	56	48	)	)	PUNCT
ajird-562	57	1	*	*	PUNCT
ajird-562	57	2	*	*	PUNCT
ajird-562	57	3	thyroid	thyroid	NOUN
ajird-562	57	4	disease	disease	NOUN
ajird-562	57	5	65(52±4,5	65(52±4,5	NUM
ajird-562	57	6	%	%	NOUN
ajird-562	57	7	)	)	PUNCT
ajird-562	57	8	5(12,5±5,2	5(12,5±5,2	NUM
ajird-562	57	9	%	%	NOUN
ajird-562	57	10	)	)	PUNCT
ajird-562	58	1	*	*	PUNCT
ajird-562	58	2	*	*	PUNCT
ajird-562	58	3	-obesity	-obesity	NOUN
ajird-562	58	4	37(29,6±4,1	37(29,6±4,1	NUM
ajird-562	58	5	%	%	NOUN
ajird-562	58	6	)	)	PUNCT
ajird-562	58	7	5(12,5±5,2	5(12,5±5,2	NUM
ajird-562	58	8	%	%	NOUN
ajird-562	58	9	)	)	PUNCT
ajird-562	58	10	*	*	PUNCT
ajird-562	58	11	-diabetes	-diabete	NOUN
ajird-562	59	1	mellitus	mellitus	NOUN
ajird-562	59	2	9(7,2±2,0	9(7,2±2,0	PROPN
ajird-562	59	3	%	%	NOUN
ajird-562	59	4	)	)	PUNCT
ajird-562	59	5	1(2,5±2,5	1(2,5±2,5	NUM
ajird-562	59	6	%	%	NOUN
ajird-562	59	7	)	)	PUNCT
ajird-562	59	8	iron	iron	NOUN
ajird-562	59	9	deficiency	deficiency	NOUN
ajird-562	59	10	anemia	anemia	NOUN
ajird-562	59	11	94(75,2±3,9	94(75,2±3,9	NUM
ajird-562	59	12	%	%	NOUN
ajird-562	59	13	)	)	PUNCT
ajird-562	59	14	3(7,5±4,2	3(7,5±4,2	NUM
ajird-562	59	15	%	%	NOUN
ajird-562	59	16	)	)	PUNCT
ajird-562	60	1	*	*	PUNCT
ajird-562	60	2	*	*	PUNCT
ajird-562	60	3	a	a	DET
ajird-562	60	4	combination	combination	NOUN
ajird-562	60	5	of	of	ADP
ajird-562	60	6	two	two	NUM
ajird-562	60	7	or	or	CCONJ
ajird-562	60	8	more	more	ADJ
ajird-562	60	9	pathologies	pathology	NOUN
ajird-562	60	10	43(34,4±4,2	43(34,4±4,2	NUM
ajird-562	60	11	%	%	NOUN
ajird-562	60	12	)	)	PUNCT
ajird-562	60	13	9(22,5±6,6	9(22,5±6,6	NUM
ajird-562	60	14	%	%	NOUN
ajird-562	60	15	)	)	PUNCT
ajird-562	60	16	note	note	NOUN
ajird-562	60	17	:	:	PUNCT
ajird-562	61	1	*	*	PUNCT
ajird-562	61	2	-р	-р	PUNCT
ajird-562	61	3	<	<	X
ajird-562	61	4	0,05	0,05	X
ajird-562	61	5	significant	significant	ADJ
ajird-562	61	6	differences	difference	NOUN
ajird-562	61	7	between	between	ADP
ajird-562	61	8	groups	group	NOUN
ajird-562	61	9	i	i	PRON
ajird-562	61	10	and	and	CCONJ
ajird-562	61	11	ii	ii	PROPN
ajird-562	61	12	*	*	PUNCT
ajird-562	61	13	*	*	PUNCT
ajird-562	61	14	-р	-р	PUNCT
ajird-562	61	15	<	<	X
ajird-562	61	16	0,001	0,001	NUM
ajird-562	61	17	significant	significant	ADJ
ajird-562	61	18	differences	difference	NOUN
ajird-562	61	19	between	between	ADP
ajird-562	61	20	groups	group	NOUN
ajird-562	61	21	i	i	PRON
ajird-562	61	22	and	and	CCONJ
ajird-562	61	23	ii	ii	PROPN
ajird-562	61	24	american	american	PROPN
ajird-562	61	25	journal	journal	PROPN
ajird-562	61	26	of	of	ADP
ajird-562	61	27	interdisciplinary	interdisciplinary	ADJ
ajird-562	61	28	research	research	NOUN
ajird-562	61	29	and	and	CCONJ
ajird-562	61	30	development	development	NOUN
ajird-562	61	31	issn	issn	PROPN
ajird-562	61	32	online	online	NOUN
ajird-562	61	33	:	:	PUNCT
ajird-562	61	34	2771	2771	NUM
ajird-562	61	35	-	-	SYM
ajird-562	61	36	8948	8948	NUM
ajird-562	61	37	website	website	NOUN
ajird-562	61	38	:	:	PUNCT
ajird-562	61	39	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-562	61	40	volume	volume	NOUN
ajird-562	61	41	14	14	NUM
ajird-562	61	42	,	,	PUNCT
ajird-562	61	43	march	march	PROPN
ajird-562	61	44	,	,	PUNCT
ajird-562	61	45	2023	2023	NUM
ajird-562	61	46	83	83	NUM
ajird-562	61	47	|	|	ADV
ajird-562	61	48	p	p	NOUN
ajird-562	61	49	a	a	DET
ajird-562	61	50	g	g	NOUN
ajird-562	61	51	e	e	NOUN
ajird-562	61	52	the	the	DET
ajird-562	61	53	analysis	analysis	NOUN
ajird-562	61	54	of	of	ADP
ajird-562	61	55	endocrine	endocrine	ADJ
ajird-562	61	56	system	system	NOUN
ajird-562	61	57	diseases	disease	NOUN
ajird-562	61	58	showed	show	VERB
ajird-562	61	59	that	that	SCONJ
ajird-562	61	60	106(84.8±3.2	106(84.8±3.2	NUM
ajird-562	61	61	%	%	NOUN
ajird-562	61	62	)	)	PUNCT
ajird-562	61	63	patients	patient	NOUN
ajird-562	61	64	in	in	ADP
ajird-562	61	65	the	the	DET
ajird-562	61	66	main	main	ADJ
ajird-562	61	67	group	group	NOUN
ajird-562	61	68	were	be	AUX
ajird-562	61	69	4.8	4.8	NUM
ajird-562	61	70	times	time	NOUN
ajird-562	61	71	more	more	ADV
ajird-562	61	72	likely	likely	ADJ
ajird-562	61	73	to	to	PART
ajird-562	61	74	have	have	VERB
ajird-562	61	75	endocrine	endocrine	NOUN
ajird-562	61	76	diseases	disease	NOUN
ajird-562	61	77	compared	compare	VERB
ajird-562	61	78	to	to	ADP
ajird-562	61	79	7(17.5±6	7(17.5±6	NUM
ajird-562	61	80	%	%	NOUN
ajird-562	61	81	)	)	PUNCT
ajird-562	61	82	controls	control	NOUN
ajird-562	61	83	,	,	PUNCT
ajird-562	61	84	p<0.05	p<0.05	PROPN
ajird-562	61	85	.	.	PROPN
ajird-562	61	86	thyroid	thyroid	PROPN
ajird-562	61	87	pathology	pathology	NOUN
ajird-562	61	88	,	,	PUNCT
ajird-562	61	89	mainly	mainly	ADV
ajird-562	61	90	diffuse	diffuse	VERB
ajird-562	61	91	goiter	goiter	NOUN
ajird-562	61	92	of	of	ADP
ajird-562	61	93	stages	stage	NOUN
ajird-562	61	94	i	i	PRON
ajird-562	61	95	and	and	CCONJ
ajird-562	61	96	ii	ii	PROPN
ajird-562	61	97	,	,	PUNCT
ajird-562	61	98	was	be	AUX
ajird-562	61	99	4	4	NUM
ajird-562	61	100	-	-	ADJ
ajird-562	61	101	fold	fold	VERB
ajird-562	61	102	more	more	ADV
ajird-562	61	103	common	common	ADJ
ajird-562	61	104	in	in	ADP
ajird-562	61	105	the	the	DET
ajird-562	61	106	main	main	ADJ
ajird-562	61	107	group	group	NOUN
ajird-562	61	108	than	than	ADP
ajird-562	61	109	in	in	ADP
ajird-562	61	110	the	the	DET
ajird-562	61	111	control	control	NOUN
ajird-562	61	112	group	group	NOUN
ajird-562	61	113	women	woman	NOUN
ajird-562	61	114	65(52±4.5	65(52±4.5	PROPN
ajird-562	61	115	%	%	NOUN
ajird-562	61	116	)	)	PUNCT
ajird-562	61	117	vs	vs	ADP
ajird-562	61	118	5(12.5±5.2	5(12.5±5.2	NUM
ajird-562	61	119	%	%	NOUN
ajird-562	61	120	)	)	PUNCT
ajird-562	61	121	respectively	respectively	ADV
ajird-562	61	122	,	,	PUNCT
ajird-562	61	123	p<0.05	p<0.05	NOUN
ajird-562	61	124	.	.	PUNCT
ajird-562	62	1	patients	patient	NOUN
ajird-562	62	2	in	in	ADP
ajird-562	62	3	the	the	DET
ajird-562	62	4	main	main	ADJ
ajird-562	62	5	group	group	NOUN
ajird-562	62	6	37(29.6±4.1	37(29.6±4.1	NUM
ajird-562	62	7	%	%	NOUN
ajird-562	62	8	)	)	PUNCT
ajird-562	62	9	were	be	AUX
ajird-562	62	10	2.4	2.4	NUM
ajird-562	62	11	times	time	NOUN
ajird-562	62	12	more	more	ADV
ajird-562	62	13	likely	likely	ADJ
ajird-562	62	14	to	to	PART
ajird-562	62	15	be	be	AUX
ajird-562	62	16	overweight	overweight	ADJ
ajird-562	62	17	5(12.5±5.2	5(12.5±5.2	NUM
ajird-562	62	18	%	%	NOUN
ajird-562	62	19	)	)	PUNCT
ajird-562	62	20	,	,	PUNCT
ajird-562	62	21	p<0.05	p<0.05	PROPN
ajird-562	62	22	.	.	PUNCT
ajird-562	63	1	diabetes	diabetes	NOUN
ajird-562	63	2	mellitus	mellitus	NOUN
ajird-562	63	3	in	in	ADP
ajird-562	63	4	patients	patient	NOUN
ajird-562	63	5	in	in	ADP
ajird-562	63	6	the	the	DET
ajird-562	63	7	main	main	ADJ
ajird-562	63	8	group	group	NOUN
ajird-562	63	9	9(7.2±2.0	9(7.2±2.0	NUM
ajird-562	63	10	%	%	NOUN
ajird-562	63	11	)	)	PUNCT
ajird-562	63	12	was	be	AUX
ajird-562	63	13	also	also	ADV
ajird-562	63	14	significantly	significantly	ADV
ajird-562	63	15	more	more	ADV
ajird-562	63	16	common	common	ADJ
ajird-562	63	17	than	than	ADP
ajird-562	63	18	in	in	ADP
ajird-562	63	19	controls	control	NOUN
ajird-562	63	20	1(2.5±2.5	1(2.5±2.5	NUM
ajird-562	63	21	%	%	NOUN
ajird-562	63	22	)	)	PUNCT
ajird-562	63	23	,	,	PUNCT
ajird-562	63	24	p<0.05	p<0.05	PROPN
ajird-562	63	25	.	.	PUNCT
ajird-562	64	1	iron	iron	NOUN
ajird-562	64	2	deficiency	deficiency	NOUN
ajird-562	64	3	anemia	anemia	NOUN
ajird-562	64	4	was	be	AUX
ajird-562	64	5	diagnosed	diagnose	VERB
ajird-562	64	6	in	in	ADP
ajird-562	64	7	94(75.2±3.9	94(75.2±3.9	NUM
ajird-562	64	8	%	%	NOUN
ajird-562	64	9	)	)	PUNCT
ajird-562	64	10	patients	patient	NOUN
ajird-562	64	11	in	in	ADP
ajird-562	64	12	the	the	DET
ajird-562	64	13	main	main	ADJ
ajird-562	64	14	group	group	NOUN
ajird-562	64	15	and	and	CCONJ
ajird-562	64	16	only	only	ADV
ajird-562	64	17	three	three	NUM
ajird-562	64	18	(	(	PUNCT
ajird-562	64	19	7.5±4.2	7.5±4.2	NUM
ajird-562	64	20	%	%	NOUN
ajird-562	64	21	)	)	PUNCT
ajird-562	64	22	in	in	ADP
ajird-562	64	23	the	the	DET
ajird-562	64	24	control	control	NOUN
ajird-562	64	25	group	group	NOUN
ajird-562	64	26	,	,	PUNCT
ajird-562	64	27	p<0.001	p<0.001	PROPN
ajird-562	64	28	.	.	PUNCT
ajird-562	65	1	patients	patient	NOUN
ajird-562	65	2	in	in	ADP
ajird-562	65	3	the	the	DET
ajird-562	65	4	main	main	ADJ
ajird-562	65	5	group	group	NOUN
ajird-562	65	6	were	be	AUX
ajird-562	65	7	1.5	1.5	NUM
ajird-562	65	8	times	time	NOUN
ajird-562	65	9	more	more	ADV
ajird-562	65	10	likely	likely	ADJ
ajird-562	65	11	to	to	PART
ajird-562	65	12	have	have	VERB
ajird-562	65	13	a	a	DET
ajird-562	65	14	combination	combination	NOUN
ajird-562	65	15	of	of	ADP
ajird-562	65	16	two	two	NUM
ajird-562	65	17	or	or	CCONJ
ajird-562	65	18	more	more	ADJ
ajird-562	65	19	pathologies	pathology	NOUN
ajird-562	65	20	.	.	PUNCT
ajird-562	66	1	thus	thus	ADV
ajird-562	66	2	,	,	PUNCT
ajird-562	66	3	somatic	somatic	ADJ
ajird-562	66	4	diseases	disease	NOUN
ajird-562	66	5	occurred	occur	VERB
ajird-562	66	6	in	in	ADP
ajird-562	66	7	all	all	DET
ajird-562	66	8	patients	patient	NOUN
ajird-562	66	9	with	with	ADP
ajird-562	66	10	eh	eh	INTJ
ajird-562	66	11	and	and	CCONJ
ajird-562	66	12	bbc	bbc	PROPN
ajird-562	66	13	,	,	PUNCT
ajird-562	66	14	and	and	CCONJ
ajird-562	66	15	the	the	DET
ajird-562	66	16	combination	combination	NOUN
ajird-562	66	17	of	of	ADP
ajird-562	66	18	two	two	NUM
ajird-562	66	19	or	or	CCONJ
ajird-562	66	20	more	more	ADJ
ajird-562	66	21	pathologies	pathology	NOUN
ajird-562	66	22	was	be	AUX
ajird-562	66	23	1.5	1.5	NUM
ajird-562	66	24	times	time	NOUN
ajird-562	66	25	more	more	ADV
ajird-562	66	26	frequent	frequent	ADJ
ajird-562	66	27	than	than	ADP
ajird-562	66	28	that	that	PRON
ajird-562	66	29	in	in	ADP
ajird-562	66	30	the	the	DET
ajird-562	66	31	control	control	NOUN
ajird-562	66	32	group	group	NOUN
ajird-562	66	33	.	.	PUNCT
ajird-562	67	1	references	reference	NOUN
ajird-562	67	2	:	:	PUNCT
ajird-562	68	1	1	1	NUM
ajird-562	68	2	.	.	X
ajird-562	68	3	аблакулова	аблакулова	PROPN
ajird-562	68	4	в.с	в.с	PROPN
ajird-562	68	5	.	.	PROPN
ajird-562	68	6	о	о	PROPN
ajird-562	68	7	риске	риске	PROPN
ajird-562	68	8	рецидирования	рецидирования	PROPN
ajird-562	68	9	полипов	полипов	PROPN
ajird-562	68	10	эндометрия	эндометрия	NOUN
ajird-562	68	11	.	.	PUNCT
ajird-562	69	1	второй	второй	PROPN
ajird-562	69	2	мед	мед	PROPN
ajird-562	69	3	журнал	журнал	PROPN
ajird-562	69	4	.	.	PUNCT
ajird-562	70	1	узбекистана	узбекистана	PROPN
ajird-562	70	2	.	.	PUNCT
ajird-562	71	1	1999	1999	NUM
ajird-562	71	2	;	;	PUNCT
ajird-562	71	3	1	1	NUM
ajird-562	71	4	;	;	PUNCT
ajird-562	71	5	53	53	NUM
ajird-562	71	6	-	-	PUNCT
ajird-562	71	7	55с	55с	NUM
ajird-562	71	8	.	.	PUNCT
ajird-562	72	1	2	2	X
ajird-562	72	2	.	.	X
ajird-562	72	3	айламазян	айламазян	PROPN
ajird-562	72	4	э	э	X
ajird-562	72	5	.	.	PUNCT
ajird-562	73	1	к	к	X
ajird-562	73	2	.	.	PUNCT
ajird-562	73	3	гинекология	гинекология	NOUN
ajird-562	73	4	:	:	PUNCT
ajird-562	73	5	от	от	ADP
ajird-562	73	6	пубертата	пубертата	NOUN
ajird-562	73	7	до	до	INTJ
ajird-562	73	8	менопаузы	менопаузы	PROPN
ajird-562	73	9	.	.	PUNCT
ajird-562	73	10	—	—	PUNCT
ajird-562	74	1	м	м	X
ajird-562	74	2	.	.	PUNCT
ajird-562	74	3	:	:	PUNCT
ajird-562	75	1	медпресс	медпресс	ADJ
ajird-562	75	2	,	,	PUNCT
ajird-562	75	3	2017	2017	NUM
ajird-562	75	4	.	.	PUNCT
ajird-562	75	5	—	—	PUNCT
ajird-562	75	6	512	512	NUM
ajird-562	75	7	с	с	NOUN
ajird-562	75	8	.	.	PROPN
ajird-562	76	1	3	3	X
ajird-562	76	2	.	.	PUNCT
ajird-562	76	3	алиева	алиева	PROPN
ajird-562	77	1	д.а	д.а	AUX
ajird-562	77	2	.	.	PROPN
ajird-562	77	3	,	,	PUNCT
ajird-562	77	4	аскарова	аскарова	NOUN
ajird-562	77	5	з.з	з.з	PROPN
ajird-562	77	6	.	.	PROPN
ajird-562	77	7	,	,	PUNCT
ajird-562	77	8	каримова	каримова	VERB
ajird-562	77	9	г.с	г.с	PROPN
ajird-562	77	10	.	.	PROPN
ajird-562	77	11	,	,	PUNCT
ajird-562	77	12	значение	значение	PROPN
ajird-562	77	13	гистероскопии	гистероскопии	NOUN
ajird-562	77	14	в	в	PROPN
ajird-562	77	15	диагностике	диагностике	VERB
ajird-562	77	16	аномальных	аномальных	PROPN
ajird-562	77	17	маточных	маточных	PROPN
ajird-562	77	18	кровотечений	кровотечений	PROPN
ajird-562	77	19	в	в	PROPN
ajird-562	77	20	перименопаузевопросы	перименопаузевопросы	VERB
ajird-562	77	21	науки	науки	PROPN
ajird-562	77	22	и	и	PROPN
ajird-562	77	23	образования	образования	NOUN
ajird-562	77	24	.	.	PUNCT
ajird-562	78	1	2020.-20	2020.-20	NUM
ajird-562	78	2	-	-	NOUN
ajird-562	78	3	26с	26с	NUM
ajird-562	78	4	4	4	NUM
ajird-562	78	5	.	.	PUNCT
ajird-562	79	1	аскарова	аскарова	PROPN
ajird-562	79	2	з.з	з.з	PROPN
ajird-562	79	3	.	.	PROPN
ajird-562	79	4	частота	частота	PROPN
ajird-562	80	1	патоморфологических	патоморфологических	PROPN
ajird-562	80	2	изменений	изменений	PROPN
ajird-562	80	3	эндо	эндо	NOUN
ajird-562	80	4	-	-	PUNCT
ajird-562	80	5	и	и	NOUN
ajird-562	80	6	миометрия	миометрия	NOUN
ajird-562	80	7	в	в	X
ajird-562	80	8	развитие	развитие	ADJ
ajird-562	80	9	аномальных	аномальных	PROPN
ajird-562	80	10	маточных	маточных	PROPN
ajird-562	80	11	кровотечений	кровотечений	PROPN
ajird-562	81	1	у	у	PROPN
ajird-562	81	2	женщин	женщин	PROPN
ajird-562	81	3	в	в	PROPN
ajird-562	81	4	перименопаузе	перименопаузе	ADJ
ajird-562	81	5	достижение	достижение	PROPN
ajird-562	81	6	науки	науки	PROPN
ajird-562	81	7	и	и	PROPN
ajird-562	81	8	образования,2020.-113	образования,2020.-113	PROPN
ajird-562	81	9	-	-	PUNCT
ajird-562	81	10	116с	116с	PROPN
ajird-562	81	11	.	.	PUNCT
ajird-562	82	1	5	5	NUM
ajird-562	82	2	.	.	PUNCT
ajird-562	82	3	алиева	алиева	PROPN
ajird-562	82	4	д	д	PROPN
ajird-562	82	5	.	.	PUNCT
ajird-562	82	6	а	а	PROPN
ajird-562	82	7	.	.	PROPN
ajird-562	82	8	,	,	PUNCT
ajird-562	82	9	аскарова	аскарова	VERB
ajird-562	82	10	з	з	X
ajird-562	82	11	.	.	PUNCT
ajird-562	82	12	з	з	X
ajird-562	82	13	.	.	PROPN
ajird-562	82	14	,	,	PUNCT
ajird-562	82	15	каримова	каримова	VERB
ajird-562	82	16	г	г	PROPN
ajird-562	82	17	.	.	PUNCT
ajird-562	83	1	с	с	PROPN
ajird-562	83	2	.	.	PUNCT
ajird-562	84	1	значение	значение	PROPN
ajird-562	84	2	гистероскопии	гистероскопии	PROPN
ajird-562	84	3	в	в	PROPN
ajird-562	84	4	диагностике	диагностике	VERB
ajird-562	84	5	аномальных	аномальных	PROPN
ajird-562	84	6	маточных	маточных	PROPN
ajird-562	84	7	кровотечений	кровотечений	PROPN
ajird-562	84	8	в	в	PROPN
ajird-562	84	9	перименопаузе	перименопаузе	PROPN
ajird-562	84	10	//вопросы	//вопросы	PUNCT
ajird-562	85	1	науки	науки	PROPN
ajird-562	85	2	и	и	PROPN
ajird-562	85	3	образования	образования	NOUN
ajird-562	85	4	.	.	PUNCT
ajird-562	85	5	–	–	PUNCT
ajird-562	85	6	2020	2020	NUM
ajird-562	85	7	.	.	PUNCT
ajird-562	86	1	–	–	PUNCT
ajird-562	86	2	№	№	NOUN
ajird-562	86	3	.	.	PUNCT
ajird-562	87	1	37	37	NUM
ajird-562	87	2	(	(	PUNCT
ajird-562	87	3	121	121	NUM
ajird-562	87	4	)	)	PUNCT
ajird-562	87	5	.	.	PUNCT
ajird-562	88	1	–	–	PUNCT
ajird-562	88	2	с	с	NOUN
ajird-562	88	3	.	.	PROPN
ajird-562	88	4	20	20	NUM
ajird-562	88	5	-	-	SYM
ajird-562	88	6	26	26	NUM
ajird-562	88	7	.	.	NOUN
ajird-562	89	1	6	6	NUM
ajird-562	89	2	.	.	X
ajird-562	89	3	запорожан	запорожан	PROPN
ajird-562	89	4	в	в	PROPN
ajird-562	89	5	.	.	PUNCT
ajird-562	90	1	н	н	X
ajird-562	90	2	.	.	PROPN
ajird-562	90	3	,	,	PUNCT
ajird-562	90	4	вихляева	вихляева	VERB
ajird-562	90	5	е	е	X
ajird-562	90	6	.	.	PROPN
ajird-562	91	1	м	м	NUM
ajird-562	91	2	.	.	PUNCT
ajird-562	91	3	,	,	PUNCT
ajird-562	91	4	железнов	железнов	NOUN
ajird-562	91	5	б	б	X
ajird-562	91	6	.	.	PUNCT
ajird-562	92	1	и	и	PROPN
ajird-562	92	2	.	.	PUNCT
ajird-562	92	3	дисфункциональные	дисфункциональные	NOUN
ajird-562	92	4	маточные	маточные	NOUN
ajird-562	92	5	кровотечения	кровотечения	NOUN
ajird-562	92	6	//	//	NUM
ajird-562	92	7	руководство	руководство	PROPN
ajird-562	92	8	по	по	PROPN
ajird-562	92	9	эндокринной	эндокринной	PROPN
ajird-562	92	10	гинекологии	гинекологии	PROPN
ajird-562	92	11	/	/	SYM
ajird-562	92	12	под	под	ADJ
ajird-562	92	13	ред	ред	PROPN
ajird-562	92	14	.	.	PUNCT
ajird-562	93	1	е	е	X
ajird-562	93	2	.	.	PUNCT
ajird-562	93	3	м	м	X
ajird-562	93	4	.	.	PUNCT
ajird-562	93	5	вихляевой	вихляевой	VERB
ajird-562	93	6	.	.	PUNCT
ajird-562	94	1	—	—	PUNCT
ajird-562	95	1	м	м	X
ajird-562	95	2	.	.	PUNCT
ajird-562	95	3	:	:	PUNCT
ajird-562	96	1	мед	мед	PROPN
ajird-562	96	2	.	.	PUNCT
ajird-562	97	1	информ	информ	PROPN
ajird-562	97	2	.	.	PUNCT
ajird-562	98	1	агентство	агентство	PROPN
ajird-562	98	2	,	,	PUNCT
ajird-562	98	3	2015	2015	NUM
ajird-562	98	4	.	.	PUNCT
ajird-562	98	5	—	—	PUNCT
ajird-562	98	6	768	768	NUM
ajird-562	98	7	с	с	NOUN
ajird-562	98	8	.	.	PROPN
ajird-562	99	1	7	7	NUM
ajird-562	99	2	.	.	NUM
ajird-562	99	3	савельева	савельева	NOUN
ajird-562	99	4	г	г	PROPN
ajird-562	99	5	.	.	PROPN
ajird-562	100	1	м	м	NUM
ajird-562	100	2	.	.	PROPN
ajird-562	100	3	,	,	PUNCT
ajird-562	100	4	бреусенко	бреусенко	PROPN
ajird-562	100	5	в	в	X
ajird-562	100	6	.	.	PUNCT
ajird-562	101	1	г	г	PROPN
ajird-562	101	2	.	.	PROPN
ajird-562	101	3	,	,	PUNCT
ajird-562	101	4	каплушева	каплушева	NOUN
ajird-562	102	1	л	л	PROPN
ajird-562	102	2	.	.	PUNCT
ajird-562	103	1	м	м	X
ajird-562	103	2	.	.	PUNCT
ajird-562	103	3	гистероскопия	гистероскопия	PROPN
ajird-562	103	4	.	.	PUNCT
ajird-562	104	1	м	м	X
ajird-562	104	2	.	.	PUNCT
ajird-562	105	1	:	:	PUNCT
ajird-562	105	2	гэотар	гэотар	PROPN
ajird-562	105	3	,	,	PUNCT
ajird-562	105	4	1999	1999	NUM
ajird-562	105	5	.	.	PUNCT
ajird-562	106	1	176	176	NUM
ajird-562	106	2	с	с	NOUN
ajird-562	106	3	.	.	PROPN
ajird-562	106	4	8	8	NUM
ajird-562	106	5	.	.	PUNCT
ajird-562	107	1	тоджиева	тоджиева	NOUN
ajird-562	107	2	н.и	н.и	PROPN
ajird-562	107	3	.	.	PROPN
ajird-562	107	4	,	,	PUNCT
ajird-562	107	5	худоярова	худоярова	PROPN
ajird-562	108	1	д.р	д.р	PROPN
ajird-562	108	2	.	.	PROPN
ajird-562	108	3	,	,	PUNCT
ajird-562	108	4	базарова	базарова	PROPN
ajird-562	108	5	з.з.совершенствование	з.з.совершенствование	ADJ
ajird-562	108	6	методов	методов	NOUN
ajird-562	108	7	лечения	лечения	VERB
ajird-562	108	8	гиперпластических	гиперпластических	NOUN
ajird-562	108	9	процессов	процессов	NOUN
ajird-562	108	10	эндометрия	эндометрия	NOUN
ajird-562	108	11	в	в	PROPN
ajird-562	108	12	пременопаузепрофессионал	пременопаузепрофессионал	PROPN
ajird-562	108	13	года	года	NOUN
ajird-562	108	14	.	.	PUNCT
ajird-562	109	1	2018	2018	NUM
ajird-562	109	2	.	.	PUNCT
ajird-562	110	1	81	81	NUM
ajird-562	110	2	-	-	PUNCT
ajird-562	110	3	84с	84с	NUM
ajird-562	110	4	american	american	ADJ
ajird-562	110	5	journal	journal	PROPN
ajird-562	110	6	of	of	ADP
ajird-562	110	7	interdisciplinary	interdisciplinary	ADJ
ajird-562	110	8	research	research	NOUN
ajird-562	110	9	and	and	CCONJ
ajird-562	110	10	development	development	NOUN
ajird-562	110	11	issn	issn	PROPN
ajird-562	110	12	online	online	NOUN
ajird-562	110	13	:	:	PUNCT
ajird-562	110	14	2771	2771	NUM
ajird-562	110	15	-	-	SYM
ajird-562	110	16	8948	8948	NUM
ajird-562	110	17	website	website	NOUN
ajird-562	110	18	:	:	PUNCT
ajird-562	110	19	www.ajird.journalspark.org	www.ajird.journalspark.org	ADJ
ajird-562	110	20	volume	volume	NOUN
ajird-562	110	21	14	14	NUM
ajird-562	110	22	,	,	PUNCT
ajird-562	110	23	march	march	PROPN
ajird-562	110	24	,	,	PUNCT
ajird-562	110	25	2023	2023	NUM
ajird-562	110	26	84	84	NUM
ajird-562	111	1	|	|	ADV
ajird-562	111	2	p	p	ADP
ajird-562	111	3	a	a	DET
ajird-562	111	4	g	g	NOUN
ajird-562	111	5	e	e	NOUN
ajird-562	111	6	9	9	NUM
ajird-562	111	7	.	.	PUNCT
ajird-562	112	1	тоджиева	тоджиева	NOUN
ajird-562	112	2	н	н	VERB
ajird-562	112	3	.	.	PUNCT
ajird-562	113	1	и	и	PROPN
ajird-562	113	2	.	.	PROPN
ajird-562	113	3	premenopauzal	premenopauzal	PROPN
ajird-562	113	4	davrdagi	davrdagi	PROPN
ajird-562	113	5	endometriyning	endometriyne	VERB
ajird-562	113	6	giperplastik	giperplastik	NOUN
ajird-562	113	7	jarayonlari	jarayonlari	PROPN
ajird-562	113	8	:	:	PUNCT
ajird-562	113	9	davolash	davolash	PROPN
ajird-562	113	10	usullarini	usullarini	PROPN
ajird-562	113	11	takomillashtirish	takomillashtirish	PROPN
ajird-562	113	12	//журнал	//журнал	PUNCT
ajird-562	113	13	биомедицины	биомедицины	NOUN
ajird-562	113	14	и	и	X
ajird-562	113	15	практики	практики	ADJ
ajird-562	113	16	.	.	PUNCT
ajird-562	114	1	–	–	PUNCT
ajird-562	114	2	2022	2022	NUM
ajird-562	114	3	.	.	PUNCT
ajird-562	115	1	–	–	PUNCT
ajird-562	115	2	т	т	X
ajird-562	115	3	.	.	NOUN
ajird-562	115	4	7	7	NUM
ajird-562	115	5	.	.	X
ajird-562	115	6	–	–	PUNCT
ajird-562	115	7	№	№	NOUN
ajird-562	115	8	.	.	NOUN
ajird-562	116	1	5	5	NUM
ajird-562	116	2	.	.	NOUN
ajird-562	116	3	10	10	NUM
ajird-562	116	4	.	.	PUNCT
ajird-562	117	1	american	american	PROPN
ajird-562	117	2	college	college	PROPN
ajird-562	117	3	of	of	ADP
ajird-562	117	4	obstetrics	obstetric	NOUN
ajird-562	117	5	and	and	CCONJ
ajird-562	117	6	gynecology	gynecology	NOUN
ajird-562	117	7	.	.	PUNCT
ajird-562	118	1	practice	practice	NOUN
ajird-562	118	2	bulletin	bulletin	NOUN
ajird-562	118	3	no	no	INTJ
ajird-562	118	4	.	.	PROPN
ajird-562	118	5	128	128	NUM
ajird-562	118	6	,	,	PUNCT
ajird-562	118	7	diagnosis	diagnosis	NOUN
ajird-562	118	8	of	of	ADP
ajird-562	118	9	abnormal	abnormal	ADJ
ajird-562	118	10	uterine	uterine	ADJ
ajird-562	118	11	bleeding	bleeding	NOUN
ajird-562	118	12	in	in	ADP
ajird-562	118	13	reproductive	reproductive	ADJ
ajird-562	118	14	aged	aged	ADJ
ajird-562	118	15	women	woman	NOUN
ajird-562	118	16	.	.	PUNCT
ajird-562	119	1	obstetgynecol	obstetgynecol	PROPN
ajird-562	119	2	.	.	PUNCT
ajird-562	120	1	2012;120:197	2012;120:197	NUM
ajird-562	120	2	-	-	SYM
ajird-562	120	3	206	206	NUM
ajird-562	120	4	.	.	PUNCT
ajird-562	121	1	11	11	NUM
ajird-562	121	2	.	.	PUNCT
ajird-562	122	1	askarova	askarova	PROPN
ajird-562	122	2	z.	z.	PROPN
ajird-562	122	3	z.	z.	PROPN
ajird-562	122	4	et	et	PROPN
ajird-562	122	5	al	al	PROPN
ajird-562	122	6	.	.	PROPN
ajird-562	122	7	value	value	NOUN
ajird-562	122	8	of	of	ADP
ajird-562	122	9	hysteroscopy	hysteroscopy	NOUN
ajird-562	122	10	and	and	CCONJ
ajird-562	122	11	genetic	genetic	ADJ
ajird-562	122	12	research	research	NOUN
ajird-562	122	13	of	of	ADP
ajird-562	122	14	women	woman	NOUN
ajird-562	122	15	with	with	ADP
ajird-562	122	16	abnormal	abnormal	ADJ
ajird-562	122	17	uterine	uterine	ADJ
ajird-562	122	18	bleeding	bleeding	NOUN
ajird-562	122	19	in	in	ADP
ajird-562	122	20	perimenopause	perimenopause	NOUN
ajird-562	122	21	//eur	//eur	PUNCT
ajird-562	123	1	j	j	PROPN
ajird-562	123	2	mol	mol	PROPN
ajird-562	123	3	clin	clin	PROPN
ajird-562	123	4	med	med	PROPN
ajird-562	123	5	.	.	PUNCT
ajird-562	124	1	–	–	PUNCT
ajird-562	124	2	2021	2021	NUM
ajird-562	124	3	.	.	PUNCT
ajird-562	125	1	–	–	PUNCT
ajird-562	125	2	т	т	X
ajird-562	125	3	.	.	NOUN
ajird-562	125	4	8	8	NUM
ajird-562	125	5	.	.	X
ajird-562	125	6	–	–	PUNCT
ajird-562	125	7	№	№	NOUN
ajird-562	125	8	.	.	NOUN
ajird-562	126	1	1	1	NUM
ajird-562	126	2	.	.	X
ajird-562	126	3	–	–	PUNCT
ajird-562	126	4	с	с	PROPN
ajird-562	126	5	.	.	PUNCT
ajird-562	126	6	409	409	NUM
ajird-562	126	7	-	-	SYM
ajird-562	126	8	416	416	NUM
ajird-562	126	9	.	.	PUNCT
ajird-562	126	10	12	12	NUM
ajird-562	126	11	.	.	PUNCT
ajird-562	127	1	barbieri	barbieri	PROPN
ajird-562	127	2	rl	rl	PROPN
ajird-562	127	3	.	.	PUNCT
ajird-562	128	1	a	a	DET
ajird-562	128	2	new	new	ADJ
ajird-562	128	3	(	(	PUNCT
ajird-562	128	4	to	to	ADP
ajird-562	128	5	the	the	DET
ajird-562	128	6	us	us	PROPN
ajird-562	128	7	)	)	PUNCT
ajird-562	128	8	first	first	ADJ
ajird-562	128	9	-	-	PUNCT
ajird-562	128	10	line	line	NOUN
ajird-562	128	11	agent	agent	NOUN
ajird-562	128	12	for	for	ADP
ajird-562	128	13	heavy	heavy	ADJ
ajird-562	128	14	menstrual	menstrual	ADJ
ajird-562	128	15	bleeding	bleeding	NOUN
ajird-562	128	16	(	(	PUNCT
ajird-562	128	17	editorial	editorial	NOUN
ajird-562	128	18	)	)	PUNCT
ajird-562	128	19	.	.	PUNCT
ajird-562	129	1	obg	obg	NOUN
ajird-562	129	2	management	management	NOUN
ajird-562	129	3	.	.	PUNCT
ajird-562	130	1	2010;22:9	2010;22:9	NUM
ajird-562	130	2	-	-	SYM
ajird-562	130	3	12	12	NUM
ajird-562	130	4	.	.	PUNCT
ajird-562	131	1	13	13	NUM
ajird-562	131	2	.	.	PUNCT
ajird-562	132	1	basila	basila	PROPN
ajird-562	132	2	d	d	PROPN
ajird-562	132	3	,	,	PUNCT
ajird-562	132	4	yuan	yuan	PROPN
ajird-562	132	5	cs	cs	PROPN
ajird-562	132	6	.	.	PROPN
ajird-562	132	7	effects	effect	NOUN
ajird-562	132	8	of	of	ADP
ajird-562	132	9	dietary	dietary	ADJ
ajird-562	132	10	supplements	supplement	NOUN
ajird-562	132	11	on	on	ADP
ajird-562	132	12	coagulation	coagulation	NOUN
ajird-562	132	13	and	and	CCONJ
ajird-562	132	14	platelet	platelet	NOUN
ajird-562	132	15	function	function	NOUN
ajird-562	132	16	.	.	PUNCT
ajird-562	133	1	thromb	thromb	NOUN
ajird-562	133	2	res	re	NOUN
ajird-562	133	3	.	.	PUNCT
ajird-562	134	1	2015;117:49	2015;117:49	NUM
ajird-562	134	2	-	-	SYM
ajird-562	134	3	53	53	NUM
ajird-562	134	4	.	.	PUNCT
ajird-562	135	1	14	14	NUM
ajird-562	135	2	.	.	PUNCT
ajird-562	136	1	bosteels	bosteels	PROPN
ajird-562	136	2	j	j	PROPN
ajird-562	136	3	,	,	PUNCT
ajird-562	136	4	kasius	kasius	PROPN
ajird-562	136	5	j	j	PROPN
ajird-562	136	6	,	,	PUNCT
ajird-562	136	7	weyers	weyer	NOUN
ajird-562	136	8	s.	s.	PROPN
ajird-562	136	9	hysteroscopy	hysteroscopy	VERB
ajird-562	136	10	for	for	ADP
ajird-562	136	11	treating	treat	VERB
ajird-562	136	12	subfertility	subfertility	NOUN
ajird-562	136	13	associated	associate	VERB
ajird-562	136	14	with	with	ADP
ajird-562	136	15	suspected	suspect	VERB
ajird-562	136	16	major	major	ADJ
ajird-562	136	17	uterine	uterine	ADJ
ajird-562	136	18	cavity	cavity	NOUN
ajird-562	136	19	abnormalities	abnormality	NOUN
ajird-562	136	20	.	.	PUNCT
ajird-562	137	1	cochrane	cochrane	NOUN
ajird-562	137	2	database	database	PROPN
ajird-562	137	3	syst	syst	PROPN
ajird-562	137	4	rev	rev	PROPN
ajird-562	137	5	.	.	PUNCT
ajird-562	137	6	2015;2	2015;2	NUM
ajird-562	137	7	:	:	PUNCT
ajird-562	137	8	cd009461	cd009461	ADJ
ajird-562	137	9	.	.	PUNCT
ajird-562	138	1	15	15	NUM
ajird-562	138	2	.	.	PUNCT
ajird-562	138	3	iskandarovna	iskandarovna	PROPN
ajird-562	138	4	t.	t.	PROPN
ajird-562	138	5	n.	n.	PROPN
ajird-562	138	6	,	,	PUNCT
ajird-562	139	1	rakhimovna	rakhimovna	PROPN
ajird-562	139	2	k.	k.	PROPN
ajird-562	139	3	d.	d.	PROPN
ajird-562	139	4	risk	risk	NOUN
ajird-562	139	5	factors	factor	NOUN
ajird-562	139	6	for	for	ADP
ajird-562	139	7	the	the	DET
ajird-562	139	8	development	development	NOUN
ajird-562	139	9	of	of	ADP
ajird-562	139	10	endometrial	endometrial	ADJ
ajird-562	139	11	hyperplastic	hyperplastic	ADJ
ajird-562	139	12	processes	process	NOUN
ajird-562	139	13	in	in	ADP
ajird-562	139	14	premenopause	premenopause	NOUN
ajird-562	139	15	//биомедицина	//биомедицина	X
ajird-562	139	16	ва	ва	ADP
ajird-562	139	17	амалиёт	амалиёт	PROPN
ajird-562	139	18	журнали	журнали	PROPN
ajird-562	139	19	.	.	PUNCT
ajird-562	140	1	–	–	PUNCT
ajird-562	140	2	с	с	PROPN
ajird-562	140	3	.	.	PROPN
ajird-562	140	4	72	72	NUM
ajird-562	140	5	.	.	X
ajird-562	141	1	16	16	NUM
ajird-562	141	2	.	.	PUNCT
ajird-562	142	1	fozilovna	fozilovna	PROPN
ajird-562	142	2	a.	a.	NOUN
ajird-562	142	3	o.	o.	PROPN
ajird-562	142	4	,	,	PUNCT
ajird-562	142	5	raximovna	raximovna	VERB
ajird-562	142	6	x.	x.	PROPN
ajird-562	142	7	d.	d.	PROPN
ajird-562	142	8	аntiphospholipiid	аntiphospholipiid	PROPN
ajird-562	142	9	syndrome	syndrome	PROPN
ajird-562	142	10	and	and	CCONJ
ajird-562	142	11	mission	mission	NOUN
ajird-562	142	12	of	of	ADP
ajird-562	142	13	pregnancy	pregnancy	NOUN
ajird-562	142	14	//umuminsoniy	//umuminsoniy	PUNCT
ajird-562	143	1	vа	vа	AUX
ajird-562	143	2	milliy	milliy	ADJ
ajird-562	143	3	qаdriyatlаr	qаdriyatlаr	ADJ
ajird-562	143	4	:	:	PUNCT
ajird-562	143	5	til	til	ADV
ajird-562	143	6	,	,	PUNCT
ajird-562	143	7	tа’lim	tа’lim	PROPN
ajird-562	143	8	vа	vа	NOUN
ajird-562	143	9	mаdаniyat	mаdаniyat	NOUN
ajird-562	143	10	.	.	PUNCT
ajird-562	144	1	–	–	PUNCT
ajird-562	144	2	2022	2022	NUM
ajird-562	144	3	.	.	PUNCT
ajird-562	145	1	–	–	PUNCT
ajird-562	145	2	т	т	X
ajird-562	145	3	.	.	NOUN
ajird-562	145	4	1	1	NUM
ajird-562	145	5	.	.	X
ajird-562	145	6	–	–	PUNCT
ajird-562	145	7	с	с	NOUN
ajird-562	145	8	.	.	PROPN
ajird-562	145	9	13	13	NUM
ajird-562	145	10	-	-	SYM
ajird-562	145	11	15	15	NUM
ajird-562	145	12	.	.	PUNCT
ajird-562	146	1	17	17	NUM
ajird-562	146	2	.	.	PUNCT
ajird-562	147	1	kurman	kurman	PROPN
ajird-562	147	2	,	,	PUNCT
ajird-562	147	3	r.j	r.j	PROPN
ajird-562	147	4	.	.	PROPN
ajird-562	147	5	endometrial	endometrial	ADJ
ajird-562	147	6	hyperplasia	hyperplasia	NOUN
ajird-562	147	7	and	and	CCONJ
ajird-562	147	8	related	relate	VERB
ajird-562	147	9	cellular	cellular	ADJ
ajird-562	147	10	changes	change	NOUN
ajird-562	147	11	.	.	PUNCT
ajird-562	148	1	/	/	PUNCT
ajird-562	148	2	r.j	r.j	PROPN
ajird-562	148	3	.	.	PROPN
ajird-562	148	4	kurman	kurman	PROPN
ajird-562	148	5	,	,	PUNCT
ajird-562	148	6	h.j	h.j	PROPN
ajird-562	148	7	.	.	PROPN
ajird-562	148	8	norris	norris	PROPN
ajird-562	148	9	//	//	PROPN
ajird-562	149	1	blaustein	blaustein	PROPN
ajird-562	149	2	’s	’s	PART
ajird-562	149	3	pathology	pathology	NOUN
ajird-562	149	4	of	of	ADP
ajird-562	149	5	the	the	DET
ajird-562	149	6	female	female	ADJ
ajird-562	149	7	genital	genital	ADJ
ajird-562	149	8	tract	tract	NOUN
ajird-562	149	9	/	/	SYM
ajird-562	149	10	ed	ed	NOUN
ajird-562	149	11	.	.	PUNCT
ajird-562	150	1	by	by	ADP
ajird-562	150	2	r.j	r.j	PROPN
ajird-562	150	3	.	.	PROPN
ajird-562	150	4	kurman	kurman	PROPN
ajird-562	150	5	–	–	PUNCT
ajird-562	150	6	5	5	NUM
ajird-562	150	7	th	th	NUM
ajird-562	150	8	ed	ed	NOUN
ajird-562	150	9	.	.	PUNCT
ajird-562	151	1	–	–	PUNCT
ajird-562	151	2	new	new	PROPN
ajird-562	151	3	york	york	PROPN
ajird-562	151	4	,	,	PUNCT
ajird-562	151	5	1995	1995	NUM
ajird-562	151	6	.	.	PUNCT
ajird-562	152	1	–	–	PUNCT
ajird-562	152	2	p.	p.	NOUN
ajird-562	152	3	411	411	NUM
ajird-562	152	4	-	-	SYM
ajird-562	152	5	437	437	NUM
ajird-562	152	6	.	.	PUNCT
ajird-562	152	7	18	18	NUM
ajird-562	152	8	.	.	PUNCT
ajird-562	153	1	todjieva	todjieva	PROPN
ajird-562	153	2	n.	n.	PROPN
ajird-562	153	3	i.	i.	PROPN
ajird-562	153	4	,	,	PUNCT
ajird-562	153	5	ugli	ugli	PROPN
ajird-562	153	6	shopulotov	shopulotov	PROPN
ajird-562	153	7	s.	s.	PROPN
ajird-562	153	8	a.	a.	NOUN
ajird-562	153	9	communication	communication	NOUN
ajird-562	153	10	of	of	ADP
ajird-562	153	11	pre	pre	NOUN
ajird-562	153	12	-	-	NOUN
ajird-562	153	13	clampsia	clampsia	NOUN
ajird-562	153	14	of	of	ADP
ajird-562	153	15	severe	severe	ADJ
ajird-562	153	16	degree	degree	NOUN
ajird-562	153	17	and	and	CCONJ
ajird-562	153	18	extrogenital	extrogenital	ADJ
ajird-562	153	19	diseases	disease	NOUN
ajird-562	153	20	//биомедицина	//биомедицина	X
ajird-562	153	21	ва	ва	ADP
ajird-562	153	22	амалиёт	амалиёт	PROPN
ajird-562	153	23	журнали	журнали	PROPN
ajird-562	153	24	.	.	PUNCT
ajird-562	154	1	–	–	PUNCT
ajird-562	154	2	с	с	PROPN
ajird-562	154	3	.	.	PROPN
ajird-562	155	1	77	77	NUM
ajird-562	155	2	.	.	NOUN
ajird-562	156	1	19	19	NUM
ajird-562	156	2	.	.	PUNCT
ajird-562	157	1	zafarjanovna	zafarjanovna	NOUN
ajird-562	157	2	k.	k.	PROPN
ajird-562	157	3	f.	f.	PROPN
ajird-562	157	4	,	,	PUNCT
ajird-562	157	5	nuralievna	nuralievna	VERB
ajird-562	157	6	s.	s.	PROPN
ajird-562	157	7	n.	n.	PROPN
ajird-562	157	8	,	,	PUNCT
ajird-562	157	9	zafarjonovna	zafarjonovna	VERB
ajird-562	157	10	a.	a.	PROPN
ajird-562	157	11	z.	z.	PROPN
ajird-562	157	12	features	feature	NOUN
ajird-562	157	13	of	of	ADP
ajird-562	157	14	the	the	DET
ajird-562	157	15	morphological	morphological	ADJ
ajird-562	157	16	structure	structure	NOUN
ajird-562	157	17	of	of	ADP
ajird-562	157	18	the	the	DET
ajird-562	157	19	endometrium	endometrium	NOUN
ajird-562	157	20	in	in	ADP
ajird-562	157	21	women	woman	NOUN
ajird-562	157	22	of	of	ADP
ajird-562	157	23	reproductive	reproductive	ADJ
ajird-562	157	24	age	age	NOUN
ajird-562	157	25	with	with	ADP
ajird-562	157	26	abnormal	abnormal	ADJ
ajird-562	157	27	uterine	uterine	ADJ
ajird-562	157	28	bleeding	bleed	VERB
ajird-562	157	29	//research	//research	PUNCT
ajird-562	157	30	journal	journal	PROPN
ajird-562	157	31	of	of	ADP
ajird-562	157	32	trauma	trauma	NOUN
ajird-562	157	33	and	and	CCONJ
ajird-562	157	34	disability	disability	NOUN
ajird-562	157	35	studies	study	NOUN
ajird-562	157	36	.	.	PUNCT
ajird-562	158	1	–	–	PUNCT
ajird-562	158	2	2022	2022	NUM
ajird-562	158	3	.	.	PUNCT
ajird-562	159	1	–	–	PUNCT
ajird-562	159	2	т	т	X
ajird-562	159	3	.	.	NOUN
ajird-562	159	4	1	1	NUM
ajird-562	159	5	.	.	X
ajird-562	159	6	–	–	PUNCT
ajird-562	159	7	№	№	NOUN
ajird-562	159	8	.	.	PUNCT
ajird-562	160	1	10	10	NUM
ajird-562	160	2	.	.	PUNCT
ajird-562	160	3	–	–	PUNCT
ajird-562	160	4	с	с	NOUN
ajird-562	160	5	.	.	PROPN
ajird-562	160	6	258	258	NUM
ajird-562	160	7	-	-	SYM
ajird-562	160	8	262	262	NUM
ajird-562	160	9	.	.	NOUN
ajird-562	160	10	20	20	NUM
ajird-562	160	11	.	.	PUNCT
ajird-562	161	1	т	т	X
ajird-562	161	2	.	.	NOUN
ajird-562	161	3	1	1	NUM
ajird-562	161	4	.	.	X
ajird-562	161	5	№	№	NOUN
ajird-562	161	6	.	.	PUNCT
ajird-562	162	1	10	10	NUM
ajird-562	162	2	.	.	PUNCT
ajird-562	163	1	с	с	PROPN
ajird-562	163	2	.	.	PROPN
ajird-562	163	3	258	258	NUM
ajird-562	163	4	-	-	SYM
ajird-562	163	5	262	262	NUM
ajird-562	163	6	.	.	PUNCT